Literature DB >> 34479406

Reactivity of (Z)-4-Aryliden-5(4H)-thiazolones: [2 + 2]-Photocycloaddition, Ring-Opening Reactions, and Influence of the Lewis Acid BF3.

Sonia Sierra1, David Dalmau1, Sheila Higuera1, Darío Cortés1, Olga Crespo1, Ana I Jimenez1, Alexandra Pop2, Cristian Silvestru2, Esteban P Urriolabeitia1.   

Abstract

The irradiation of (Z)-2-phenyl-4-aryliden-5(4H)-thiazolones 2 with blue light (465 nm) in CH2Cl2 solution promotes [2 + 2]-photocycloaddition of the exocyclic C═C bonds and the formation of the dispirocyclobutanes 3. This reaction takes place with high stereoselectivity, given that the ε-isomer (1,3 head-to-tail syn coupling) is formed in more than 90% yield in most of the cases. However, irradiation of 5(4H)-thiazolones 2 with blue light (456 nm) in dry MeOH in the presence of BF3·OEt2 leads to the monospirocyclobutanes 4 with full stereoselectivity, also affording the ε-isomer. A ring-opening reaction of only one of the thiazolone rings appears to have taken place in 4 upon methanolysis, leading to the corresponding ester and thioamide groups. The treatment of free 4-aryliden-5(4H)-thiazolones 2 with a base in alcohol (NaOR/ROH) also produces a ring-opening reaction of the heterocycle by methanolysis, although, under these reaction conditions, further intramolecular S-attack at the exocyclic C(H)═C bond and cyclization is observed, forming the dihydrothiazoles 5 or 6 as mixtures of cis (RS/SR)- and trans (RR/SS)-isomers with high diastereomeric excess. trans-(RR/SS)-Dihydrothiazoles 6 can be isolated as pure diastereoisomers by column chromatography. Surprisingly, dihydrothiazoles 5 can also be obtained by the treatment of 4-aryliden-5(4H)-thiazolones 2 with BF3·OEt2 in methanol in the absence of a base.

Entities:  

Year:  2021        PMID: 34479406      PMCID: PMC9129068          DOI: 10.1021/acs.joc.1c01458

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.198


Introduction

The [2 + 2]-photocycloaddition reaction is a powerful synthetic tool for the tailored and versatile preparation of cyclobutanes by the C—C coupling of olefinic C=C bonds.[1] The relevance of the cyclobutane ring resides in its presence as a common structural motif in natural products or synthetic compounds with strong pharmacological activity. Some examples of relevant cyclobutanes can be found in Figure .[2−7] Moreover, cyclobutanes are also interesting synthetic intermediates as they show a particular reactivity due to the high ring strain.[8−11]
Figure 1

Cyclobutanes with important pharmacological activity.

Cyclobutanes with important pharmacological activity. Figure also shows that these cyclobutanes contain many chiral centers. The development of methods for control of the stereoselectivity during cyclobutane synthesis has attracted substantial attention.[12−15] However, for photochemical processes, a high stereoselectivity is only achieved when the reactions take place in the solid state and topochemical Schmidt’s conditions are achieved. This is the case, for instance, for the synthesis of α-truxillic (Figure b) and β-truxinic acid derivatives.[16−18] In general, the [2 + 2]-photocycloadditions performed in solution suffer a lack of stereoselectivity, and the use of auxiliary reagents such as chiral templates, sensitizers or catalysts, is mandatory.[19−31] We are interested in a particular family of cyclobutanes, namely, 1,3-diaminotruxillic derivatives (Figure ), which are well-known because of their antinociceptive activity. A renewed interest in these compounds has arisen over the past few years because truxillic derivatives have been shown to be FABP (fatty acid binding protein) inhibitors and are responsible for the cellular reuptake of anandamide (an endocannabinoid neurotransmitter).[32−36] As a result, they are promising candidates in efficient treatments for chronic pain.[37] However, this is not the only outstanding pharmacological activity of truxillic derivatives as they have also been recently shown to be the only nonpeptidic GLP-1R (glucagon-like peptide receptor) agonists for the treatment of type 2 diabetes mellitus.[38−40]
Figure 2

Context of this work, comparison with previous work and main achievements.

Context of this work, comparison with previous work and main achievements. As a result of this interest, we have developed different methodologies for the stereoselective synthesis of 1,3-diaminotruxillic derivatives (Figure ). Among these, the direct irradiation of (Z)-4-aryliden-5(4H)-oxazolones 1 shows high simplicity and versatility, together with some degree of stereoselectivity (Figure , past work, path a).[41] Thus, we have shown that the [2 + 2]-photocycloaddition of oxazolones 1 can occur using low-power (less than 20W), blue light (465 nm) irradiation sources. This method works for oxazolones bearing electron-donating and electron-withdrawing substituents and gives quantitative yields of cyclobutanes in almost all cases studied. However, it requires long reaction times (up to 3 days) and affords up to four different stereoisomers, although one of them (ε) is obtained in 50–90% abundance with respect to the other isomers. This method has been complemented with another, three-step strategy in which a palladium complex behaves as a template, thus allowing the isolation of 1,3-diaminotruxillic derivatives with good yields as single isomers (Figure , past work, path b).[42−45] The (Z)-4-arylidene-5(4H)-thiazolones 2 are the sulfur counterparts of 4-arylidene-5(4H)-oxazolones 1. Despite the structural analogy, unsaturated 5(4H)-thiazolones are less well-known, and their synthetic potential is underdeveloped.[46,47] Sulfur-containing drugs exhibit remarkable pharmacological activity, and as such, they are targets of particular interest from the point of view of pharmaceutical companies.[48] Proof of this interest is the fact that there are at least 249 sulfur-containing drugs approved by the US Food and Drug Administration (FDA).[49] Thiazolones have received some attention as sulfur-containing drugs, initially during the study of penicillin (it was believed that the active substance contained a thiazolone ring rather than a thiazolidine),[50,51] and more recently as promising anticancer compounds.[52] Due to the close relationship between 5(4H)-oxazolones 1 and 5(4H)-thiazolones 2, the interesting reactivity of oxazolones to give 1,3-diaminotruxillic derivatives observed in our previous studies,[41−45] the interest in sulfur-containing compounds due to their interesting pharmacological properties, and the complete absence of previous studies in this area, we have studied the reactivity of (Z)-4-arylidene-5(4H)-thiazolones 2 in [2 + 2]-photocycloaddition reactions and in ring-opening reactions upon alcoholysis (Figure , this work). With the aim of further exploring the chemical possibilities of these substrates, and taking into account the known influence of Lewis acids on photochemical reactions[26,28,53−62] (acceleration and/or change in the orientation and selectivity of the reactions), we have examined both processes (ring opening and photocycloaddition) in the presence of a simple Lewis acid, namely BF3, and present the results obtained below.

Results and Discussion

Synthesis of (Z)-4-Arylidene-5(4H)-thiazolones 2 and [2 + 2]-Photocycloaddition by Direct Irradiation

The thiazolones 2a–2o used in this work are shown in Figure . Synthesis was carried out following the same experimental procedure reported by Rao and Filler,[46] which in turn were based on the original work of Behringer et al.[63,64] Following this method, the treatment of oxazolones 1a–1o with thioacetic acid in the presence of substoichiometric amounts of NEt3 gave the corresponding thiazolones 2a–2o as air- and moisture-stable solids. Thiazolones 2a–2o contain electron-withdrawing or electron-donating substituents at different positions of the 4-arylidene ring in order to cover the widest scope. Thiazolones 2a–2c have been described previously, although 2b was prepared using a different method,[65,66] and although thiazolones 2e, 2f, 2g, 2h, and 2j appear in Scifinder, there are either no references associated with their synthesis or no details can be found in the corresponding literature. As such, they are fully characterized here (see Supporting Information).
Figure 3

Thiazolones 2a–2o used in this work and synthetic method.

Thiazolones 2a–2o used in this work and synthetic method. The HRMS (ESI+) spectra of 2a–2o show peaks in agreement with the stoichiometries proposed in Figure . In addition, the 1H NMR spectra of 2a–2o show a pattern of peaks quite similar to that of the oxazolone precursors 1a–1o, with only the signal due to the ortho-H of the 2-Ph ring in 2a–2o showing a downfield shift with respect to the same signal in 1a–1o. The 13C NMR spectra of 2a–2o, in which the signal due to the S—C (=O) carbon appears around 195 ppm, downfield shifted by more than 20 ppm with respect to the O—C (=O) carbonyl carbon peak (around 170 ppm), are much more informative. Solutions of thiazolones 2a–2o in CH2Cl2 were then irradiated with blue light (465 nm) at room temperature using the irradiation setup described in the Experimental Section (PCB with 24 blue LEDs). This irradiation promoted the [2 + 2]-photocycloaddition of the exocyclic C=C bond of thiazolones 2 and formation of the corresponding cyclobutanes 3 (Figure ), which were isolated as air-stable solids after solvent evaporation and recrystallization from CH2Cl2/n-pentane.
Figure 4

[2 + 2]-Photocycloaddition of 4-arylidene-5(4H)-thiazolones 2 to give cyclobutanes 3.

[2 + 2]-Photocycloaddition of 4-arylidene-5(4H)-thiazolones 2 to give cyclobutanes 3. The optimum reaction time for full conversion of 2 using the PCB, as determined by 1H NMR monitoring, was 72 h. This reaction time can be shortened to 24 h if a Kessil lamp (456 nm) is used instead, probably due to the higher photonic flux of the latter. The reaction also takes place in other solvents (for instance, methanol), giving the same yield of cyclobutanes 3. Identical results were obtained in CH2Cl2 in the presence or absence of oxygen. No photocycloaddition was observed for 2i and 2l, and partial conversion was obtained for 2h, despite the photonic flux used. The scope of the reaction (Figure ) appears to be general as it takes place with full conversions and very good yields of isolated products in the presence of either electron-donating (Me, OMe) or electron-withdrawing (F, Cl, Br, NO2, CF3) substituents. A change in position of the substituents (ortho vs para) in the 4-arylidene ring is well tolerated (compare 3e with 3j or 3f with 3k), as is the presence of two substituents in the meta- and para-positions (3m–3o).
Figure 5

Scope of the [2 + 2]-photocycloaddition of thiazolones 2 to give cyclobutanes 3.

Scope of the [2 + 2]-photocycloaddition of thiazolones 2 to give cyclobutanes 3. NMR analysis of the cyclobutanes 3 represented in Figures and 5 showed that they were mainly obtained as single isomers (3a, 3g, 3h) or as mixtures of two isomers with molar ratios of 80:20 or higher (3b, 3d, 3e, 3f, 3m, 3n, 3o; see Table and Experimental Section). Given that the photocycloaddition of thiazolones 2 can afford up to 11 different isomers, the stereoselectivity of the process presented here is remarkable. A comparison of these results with those obtained with related substrates shows that the use of thiazolones results in a more selective process. For instance, we have reported the synthesis of cyclobutanes by direct [2 + 2]-photocycloaddition of 4-arylidene-5(4H)-oxazolones 1 (Figure , past work, path a).[41] This reaction takes place for only a narrow range of substituents, and the corresponding cyclobutanes were obtained as mixtures of four different isomers with similar molar ratios. However, in the case of the thiazolones studied here, the scope is much wider, and the stereoselectivity is markedly higher.
Table 1

Yields of Cyclobutanes 3, Obtained as Mixtures of Isomers, and Composition of the Mixtures

 3a3b3c3d3e3f3g3h3j3k3m3n3o
yield82100100100859210080a959810010090
ε (%)10090599196831001007165859194
α (%)0102594170029351596
others (%)  9:7          

Maximum conversion achieved.

Maximum conversion achieved. The NMR data for all cyclobutanes 3 studied showed the presence of species with high symmetry but were not conclusive because several isomers could fit with the experimental NMR data. As such, full characterization of the main isomer for cyclobutanes 3 was achieved by determining the X-ray crystal structures of derivatives 3g, 3h, and 3m, which are shown in Figures , 7, and 8, respectively.
Figure 6

X-ray crystal structure of cyclobutane 3g. Thermal ellipsoids are drawn at 50% probability.

Figure 7

X-ray crystal structure of cyclobutane 3h. Thermal ellipsoids are drawn at 50% probability.

Figure 8

X-ray crystal structure of cyclobutane 3m. Thermal ellipsoids are drawn at 50% probability.

X-ray crystal structure of cyclobutane 3g. Thermal ellipsoids are drawn at 50% probability. X-ray crystal structure of cyclobutane 3h. Thermal ellipsoids are drawn at 50% probability. X-ray crystal structure of cyclobutane 3m. Thermal ellipsoids are drawn at 50% probability. All structures clearly show the formation of the cyclobutane core by [2 + 2]-cycloaddition of the respective thiazolones. The isomer characterized in all three cases is the ε-isomer (ε), according to the isomer assignment of Stoermer and Bachér,[67,68] which is formed by the 1,3-head-to-tail coupling of two Z-thiazolones in a syn orientation. This ε-isomer is the same as that characterized as the major isomer in the [2 + 2]-photocycloaddition of oxazolones, thus suggesting that the dimerization of oxazolones and thiazolones follows the same orientation. The three structures are very similar, with the cyclobutane core showing the 1,2-cis-2,3-cis-3,4-cis configuration. The cyclobutane rings are not planar and exhibit dihedral angles of C1-C2-C101-C2 (3g) = 18.1(3)°, C1-C9-C18-C26 (3h) = 19.7(3)°, and C2-C10-C2-C10 (3m) = 22.4(3)°, which are similar to those found in related cyclobutanes.[41] In addition, the values for the remaining bond distances (Å) and angles (°) are in the usual range of values found in the literature for related structural arrangements.[38,41,43,69−74] The characterization of the main isomer in compounds 3g, 3h, and 3m as the ε-isomer allows us to extrapolate this assignment to the remaining cyclobutanes 3 prepared here even though we were unable to characterize them all by X-ray diffraction. An additional argument in this direction is the comparison of the NMR chemical shifts for the 1H and 13C nuclei of the cyclobutane ring in 3, which exhibit values that appear in very narrow ranges, thereby suggesting quite similar environments.

Effect of Lewis Acids (BF3) on the [2 + 2]-Photocycloaddition of Thiazolones 2

As mentioned in the Introduction, the presence of Lewis acids can change the rate, orientation, and/or selectivity of a given reaction.[23,28,53−62] In order to determine the influence of Lewis acids in this particular photochemical reaction, we irradiated suspensions of selected examples of thiazolones 2 with blue light (Kessil lamp, 456 nm), in methanol, in the presence of BF3·OEt2. The optimized amount of BF3·OEt2 was four equivalents with respect to thiazolone 2. After irradiation for 24 h, the conversion of 2 was complete, and cyclobutanes 4 (represented in Figure ) were isolated by simple filtration of the resulting suspensions (see Experimental Section and Supporting Information). The full characterization of these cyclobutanes 4 showed that they were obtained as single isomers in all cases studied (see below). As such, the reaction in the presence of a Lewis acid (BF3) gives a cyclobutane with the same orientation as in its absence but with full stereoselectivity, thereby improving our previous results. However, no acceleration was observed. As a result, a more restricted scope was examined.
Figure 9

Photocycloaddition of thiazolones 2 in methanol in the presence of the Lewis acid BF3·OEt2

Photocycloaddition of thiazolones 2 in methanol in the presence of the Lewis acid BF3·OEt2 The characterization of compounds 4 by HRMS and NMR spectroscopy clearly shows the formation of a cyclobutane core in which one of the thiazolones remains unchanged while the other has undergone a ring-opening reaction by methanolysis, thus giving the corresponding ester and thioamide fragments. The HRMS data for cyclobutanes 4a, 4b, 4d, and 4e reflect the dimerization of the corresponding thiazolones 2 and the incorporation of a molecule of methanol for each dimer of cyclobutane. The 1H NMR spectra of 4a–4e show signals corresponding to the presence of a single isomer in each case; in other words, the reaction is totally stereoselective for the cases studied. The ring-opening reaction is evidenced by the observation of peaks due to the ester fragment (at around 3.8 ppm) and the NH proton (a broad signal at around 8.5–8.7 ppm) with a relative intensity of 3:1. The presence of a single peak for the two chemically equivalent cyclobutane CH protons (4.8–4.9 ppm, relative intensity 2) shows that, despite the loss of symmetry produced by the ring-opening reaction, the two ArC(H) groups of the cyclobutane are still equivalent. The 13C NMR spectra of 4a–4e also show signals in agreement with the ring-opening reaction of the only heterocycle. In this respect, peaks at around 205–206 (SC=O) and 166–167 ppm (SC=N) suggest the presence of a thiazolone ring, while peaks at around 198 (HNC=S) and 169 ppm (COO) confirm the presence of ester and thioamide groups. Moreover, three different signals are observed for the cyclobutane ring, one for the two chemically equivalent CH carbons (in the 55 ppm region) and two for the quaternary carbons (at about 90 and 67 ppm). As discussed for cyclobutanes 3, there is more than one isomer whose structure fits with the HRMS and NMR data for cyclobutanes 4. In this case, there are four possible structures (syn-ε, syn-epi, anti-epi, and syn-peri);[41] therefore, the X-ray crystal structure of 4b was determined to complete the structural characterization. Crystals were obtained by slow diffusion of n-pentane into a solution of crude 4b in CH2Cl2 at −18 °C, and the structure obtained is shown in Figure .
Figure 10

X-ray crystal structure of cyclobutane 4b. Thermal ellipsoids are drawn at 50% probability.

X-ray crystal structure of cyclobutane 4b. Thermal ellipsoids are drawn at 50% probability. The structure of cyclobutane 4b shows that the isomer obtained is the ε-isomer, which is formed by the 1,3-head-to-tail coupling of two thiazolones in a syn orientation. The cyclobutane core of 4b is not planar, showing a value for the C4-C1-C2-C3 dihedral angle of 19.1(1)°, which is identical to those found in the structures of 3g, 3h, and 3m. Other internal parameters of the cyclobutane ring are also identical (within experimental error) to those found in 3g, 3h, and 3m. The structure also confirms the ring-opening reaction by methanolysis at one of the thiazolones and the corresponding presence of ester and thioamide fragments, both of which show bond distance and angle values in agreement with those found in the literature for similar types of bonds.[74] In light of the crystal structure of 4b, it can be concluded that photocycloaddition in methanol in the presence of BF3 gives cyclobutanes 4, and that cyclobutanes 3 are formed in the absence of BF3. This reaction takes place with exactly the same orientation because the same isomer out of the 11 possible cyclobutane isomers is obtained in both cases (ε-isomer). However, the reaction affords slightly different compounds as 3 contains two unaltered thiazolone rings, whereas 4 contains only one. This suggests that the Lewis acid BF3 has a small but important influence as, although neither the rate nor the orientation of the reaction are affected, the ring-opening reaction is favored in the presence of the Lewis acid. We have studied the interaction between thiazolones 2 and BF3 in MeOH both in the ground state and in the excited state. Thiazolone 2b was selected as a representative example. To analyze the interaction in the ground state, a solution of 2b in CD3OD was treated with increasing amounts of BF3·OEt2 until the molar ratio 1:4 was reached, and the result of each addition was monitored by 1H NMR spectroscopy (see Supporting Information). A comparison of the NMR spectra showed that there is no detectable interaction on the NMR time scale as all spectra were identical, and no signal underwent a change in its chemical shift. This suggests that either the interaction is very weak or it occurs to such a small extent that it cannot be detected by NMR spectroscopy. As for the excited state, the fluorescence of thiazolone 2b was examined in the absence and presence of BF3·OEt2 (Supporting Information) in methanol. Thiazolone 2b is fluorescent and shows an emission maximum at 459 nm when excited at 390 nm. After the addition of BF3·OEt2 (1–4 equiv), no changes were detected in either the maximum of the emission or its intensity. These results suggest that the Lewis acid does not have a marked influence on either the excited state or the ground state. However, the different structure of cyclobutanes 3 and 4 shows that an interaction with the Lewis acid must occur at some point in the reaction, and given the lack of reaction observed between 2b and BF3, this probably occurs after the formation of cyclobutane 3. To check this, we treated cyclobutane 3a with BF3·OEt2 in methanol for 24 h at room temperature and in the dark. The formation of 4a was evident after this time, thus suggesting that the role of BF3 is related to the promotion of the ring-opening reaction, as shown in Figure , rather than to the [2 + 2]-photocycloaddition.
Figure 11

Proposal of the mechanism for the BF3-promoted ring-opening reaction.

Proposal of the mechanism for the BF3-promoted ring-opening reaction.

Ring-Opening Reaction of Thiazolones 2: Synthesis of 4,5-Dihydrothiazoles (5, 6) and Thiazoles (7)

The easy ring-opening reaction undergone by 3 to give 4 prompted us to study the opening of the remaining thiazolone ring in 4. The opening of both heterocycles should produce cyclobutanes structurally analogous to diaminotruxillic bis-amino acids but containing sulfur in their structure. In a first attempt, we tested the classical process, namely, heating cyclobutanes 3c and 3d with a catalytic amount of a base (NaOMe) in alcohol (MeOH).[75] Surprisingly, this reaction afforded the 4,5-dihydrothiazoles 5c and 5d as a mixture of cis- and trans-diastereoisomers, as shown in Figure (upper reaction).
Figure 12

Synthesis of 4,5-dihydrothiazoles 5 by treatment of cyclobutanes 3 with NaOMe in MeOH.

Synthesis of 4,5-dihydrothiazoles 5 by treatment of cyclobutanes 3 with NaOMe in MeOH. The transformation shown in the upper reaction of Figure suggests that the reaction is most likely related to the intrinsic reactivity of the exocyclic C(H)=C bond in thiazolone 2 rather than to that of the cyclobutane skeleton in 3. For that reason, we studied the reactivity of thiazolones 2c and 2d with NaOMe in MeOH as a solvent, and the results are also shown in Figure (lower reaction). As expected, the treatment of 2c and 2d with base in alcohol gave the dihydrothiazoles 5c and 5d in virtually the same yields and diastereomeric excess as obtained when 3c and 3d were used as precursors instead. This suggests that, when heating under basic conditions, cyclobutanes 3 are not stable and a retro-[2 + 2] reaction can take place to regenerate thiazolones 2, which subsequently react with a base to give 5. Compounds 5c and 5d were characterized by HRMS and NMR spectroscopy. The 1H NMR spectra show two characteristic AB spin systems centered around 5.4 ppm, assigned to the two aliphatic protons of the (N)CH—CH (S) moiety. The value of the 3JHH coupling constant between these two protons is diagnostic for the determination of the configuration of each diastereoisomer. Thus, the major species shows a value for the 3JHH coupling constant of 6.5 Hz, which is typical for trans geometries, whereas the value found for the minor isomer is around 10 Hz, thus suggesting a cis arrangement.[76] The higher abundance of the trans-isomer is in good agreement with the lower intramolecular repulsions in this isomer. These two protons correlate (1H–13C HSQC spectra) with two C atoms at around 87 (CHN) and 55 ppm (CHS), thus showing their aliphatic character. In addition, the peak at around 194–196 ppm for thiazolones 2 (around 205–208 ppm in cyclobutanes 3), assigned to the thiocarbonyl group (S—C=O), has disappeared, and a new peak is now observed in the 170–172 ppm region. This suggests the formation of a new heterocycle, namely the 4,5-dihydrothiazole shown in Figure . This synthetic method for the preparation of dihydrothiazoles from 4-arylidene-5(4H)thiazolones 2 is novel as, to the best of our knowledge, only one previous example has been reported in the literature.[77] In that case, the reaction was performed using NaOH in water to afford the corresponding carboxylic acid.[77] Dihydrothiazoles are interesting materials due to their properties, and different synthetic methods have been reported for their preparation, most of them starting from aminothiols.[78−89] Dihydrothiazoles are versatile intermediates for the synthesis of high-value-added compounds, for instance β-cysteine and derivatives,[90−94] are present in flavours[95] and in natural products,[96−99] and show a remarkable pharmacological activity.[100−102] For all of these reasons, we decided to explore this almost unprecedented synthesis of dihydrothiazoles from thiazolones 2 in more detail. The results are presented in Figure .
Figure 13

Reactivity of thiazolones 2 with base in alcohol to give dihydrothiazoles (5 and 6) and thiazoles (7). Yields (%) correspond to the pure isolated trans-isomer.

Reactivity of thiazolones 2 with base in alcohol to give dihydrothiazoles (5 and 6) and thiazoles (7). Yields (%) correspond to the pure isolated trans-isomer. The treatment of thiazolones 2 with NaEtO in ethanol at reflux temperature gave the corresponding dihydrothiazoles 6, as shown in Figure . After the reaction, the ethanol was evaporated to dryness, the residue was extracted with CH2Cl2, and all insoluble materials were removed by filtration. Evaporation of the solvent gave an oily residue, which was shown by 1H NMR spectroscopy to be a mixture of the two diastereoisomers of dihydrothiazoles 6 in a trans/cis molar ratio in the range 86:14 to 90:10. As such, the reaction takes place with a remarkable diastereomeric excess, which is even higher than when methanol was used as a solvent. The major trans-isomer could be isolated in pure form from that mixture by column chromatography (see Experimental Section), while the minor cis-isomer could not be isolated in sufficient quantity to be characterized in most cases. The reaction shows an adequate scope, as it works in moderate to good yields for both electron-donating (6c, 6i, 6m) and electron-withdrawing (6h, 6n) substituents in the 5-aryl ring. In addition, the reaction tolerates substituents at the ortho-, meta-, and para-positions of the aryl ring. In the case of thiazolone 2n, the formation of the thiazole 7n as the major reaction product was observed. This compound was also purified and separated from 6n by column chromatography. The absence of the diagnostic AB spin system at around 5.3–5.4 ppm in the 1H NMR spectrum of 7n, and the corresponding carbons at 86 ppm and 55 ppm in the 13C NMR spectrum, as well as the presence of two new quaternary C atoms at 142 ppm, confirms the formation of thiazole 7n, the molecular structure of which determined by X-ray diffraction methods (Figure ). The formation of thiazole 7n in the reaction medium is likely due to aerobic oxidation of the precursor dihydrothiazole, which is a well-known reaction.[103] When microwaves were used instead of a conventional heating source, as in the case of the 4-NO2-substituted thiazolone 2g, complete transformation into thiazole 7g was observed in just one minute, thus meaning that formation of the dihydrothiazole is accelerated, as is its oxidation. For that reason, only conventional heating was used. The mechanism proposed for the synthesis of dihydrothiazoles 5 or 6 from thiazolones 2 is shown in Figure . The reaction seems to start with a nucleophilic attack of the alkoxide at the carbonyl carbon to form the corresponding ester group and the thioamidate fragment. Subsequent intramolecular S-attack of the sulfide at the C(H) carbon of the exocyclic C(H)=C double bond, followed by protonation of the stabilized enolate generated, results in the formation of the final dihydrothiazoles.
Figure 14

Mechanistic proposal for the synthesis of dihydrothiazoles 5 (or 6) from thiazolones 2.

Mechanistic proposal for the synthesis of dihydrothiazoles 5 (or 6) from thiazolones 2. The easy ring-opening reactions undergone by cyclobutanes 3 to give cyclobutanes 4 shown in Figures and 11 suggest that the Lewis acid BF3 fosters the attack of nucleophiles at the carbonyl carbon, which should, in principle, favor the formation of dihydrothiazoles from thiazolones. With this in mind, we attempted the reaction of thiazolones 2 with methanol, in the presence of the Lewis acid BF3·OEt2 and in the absence of a base. The results of these reactions are shown in Figure .
Figure 15

Reactivity of thiazolones 2 with MeOH in the presence of BF3; synthesis of dihydrothiazoles 5.

Reactivity of thiazolones 2 with MeOH in the presence of BF3; synthesis of dihydrothiazoles 5. The treatment of thiazolones 2 with BF3·OEt2 (4 equiv) in methanol at reflux temperature for 18 h resulted in the formation of the corresponding dihydrothiazoles 5 in good to moderate yields. The reaction does not take place at room temperature, with thiazolone 2 being recovered unchanged. At shorter reaction times (2 h) in refluxing methanol, we observed low conversions (less than 10%), along with the formation of 5 in a more or less equimolar mixture of the two diastereoisomers (range between 1.2:1 to 1.5:1). No reaction was observed in refluxing methanol in the absence of BF3. As such, in the presence of BF3, both high temperatures and long reaction times are needed to achieve full conversion of thiazolones 2 into dihydrothiazoles 5, although a base is no longer required. The reaction is tolerant to the presence of electron-donating (Me, OMe) and electron-withdrawing (F, Cl, Br, CF3) substituents at different positions of the aryl ring, thus meaning that the reaction shows an adequate scope. The main difference between this process and the reaction performed in the presence of a base (Figures and 13) is the diastereoselectivity, which is moderate to high in the presence of a base but very low or even nonexistent in the presence of BF3. Unfortunately, we have no reasonable explanation for this finding. Our mechanistic proposal to explain the role of the Lewis acid in this reaction is presented in Figure . Coordination of the carbonyl oxygen to BF3 increases the electrophilic character of the carbonyl carbon (as in Figure ), which is, therefore, more susceptible to attack by methanol. The decoordination of BF3 is followed by the formation of the sulfide, which can attack the exocyclic C(H)=C bond (see Figure ).
Figure 16

Mechanistic proposal for the formation of dihydrothiazoles in the presence of BF3.

Mechanistic proposal for the formation of dihydrothiazoles in the presence of BF3.

Conclusion

In summary, new (Z)-4-aryliden-5(4H)-thiazolones 2 have been prepared by treatment of oxazolones with thioacetic acid. These thiazolones have been shown to be convenient and versatile precursors for the synthesis of a wide variety of carbo- and heterocycles with high selectivity. The irradiation of thiazolones 2 with blue light (465 nm) results in the formation of diaminotruxillic-type cyclobutanes 3 by head-to-tail 1,3-syn coupling [2 + 2]-photocycloaddition of thiazolones 2. The reaction shows a high stereoselectivity as cyclobutanes 3 are obtained mostly as the ε isomer. When the photochemical reaction is performed in the presence of a Lewis acid (BF3·OEt2), the reaction follows the same orientation (head-to-tail 1,3-coupling), but an additional ring-opening reaction is observed, due to bonding of the BF3, thus giving a different family of truxillic cyclobutanes 4. The role of the Lewis acid is to foster the electrophilic character of the carbonyl carbon, thereby favoring the ring-opening reaction. In addition, treatment of 2 with base NaOR in alcohol ROH affords dihydrothiazoles 5, 6 via a ring-opening reaction followed by S-intramolecular attack at the exocyclic C(H)=C bond. The reaction is highly stereoselective, with the trans-isomer being obtained as a major isomer in all cases studied. Dihydrothiazoles 5 can also be obtained by treatment of the thiazolone 2 with alcohol in the presence of BF3 but in the absence of a base. In this case, the reaction shows a broader scope, and it seems that the role of BF3 is to increase the electrophilic character of both the carbonyl carbon and the vinyl carbon.

Experimental Section

General Methods

All solvents used are commercial-grade and were used as received. All reactions were performed at open-air without special caution against the moisture and oxygen, except the syntheses of compounds 4, which were carried out under Ar atmosphere using dry and deoxygenated methanol. Flash column liquid chromatographies were performed on silica gel (70–230 μm) or aluminum oxide 90 neutral (50–200 μm), eluting with the solvents specified on each case. Elemental analyses (CHNS) were carried out on a Perkin-Elmer 2400 Series II microanalyzer. Infrared spectra (4000–380 cm–1) were recorded on a Perkin-Elmer Spectrum-100 IR spectrophotometer. 1H, 13C, and 19F NMR spectra were recorded in CDCl3 or CD2Cl2 solutions at 25 °C on Bruker AV300 or AV500 spectrometers (δ in ppm, J in Hz) at 1H operating frequency of 300.13 or 500.13 MHz, respectively. 1H and 13C spectra were referenced using the solvent signal as internal standard, while 19F spectra were referenced to CFCl3. The assignment of 1H NMR peaks has been performed through standard 2D 1H–COSY (2K points in t2 using a spectral width of 12 ppm; 128 t1 experiments were recorded and zero-filled to 1K; for each t1 value, two scans were signal-averaged using a recycle delay of 1 s) and selective 1D 1H-NOESY experiments. Typical mixing times in the case of selective 1D-NOESY experiments were in the range 1.0–2.0 s, as a function of the irradiated signal. These values of optimized mixing times were set equal to the longitudinal relaxation time T1, determined using the inversion–recovery sequence. The 13C NMR peaks were identified using standard 1H–13C edited-HSQC and 1H–13C HMBC 2D experiments. In both cases, 4K points in t2 using spectral widths of 10 ppm (1H) and 200 ppm (13C) were used, with averaged values of the coupling constants 1JCH = 145 Hz and long-range JCH = 10 Hz. Typically, 128 t1 experiments were recorded and zero-filled to 1 K. For each t1 value, 8 (HSQC) or 32 (HMBC) scans were signal-averaged using a recycle delay of 1 s. ESI (ESI+) mass spectra were recorded using an Esquire 3000 ion-trap mass spectrometer (Bruker Daltonic GmbH) equipped with a standard ESI/APCI source. Samples were introduced by direct infusion with a syringe pump. Nitrogen served both as the nebulizer gas and the dry gas. MALDI mass spectra were recorded using a Bruker MicroFlexTM or a Bruker AutoFlexTMIII spectrometer, equipped with a time-of-flight mass analyzer, and using DIT (dithranol) as a matrix. The sample was dissolved in CH2Cl2. The HRMS mass spectra were recorded using a MicroToF Q, API-Q-ToF ESI with a mass range from 20 to 3000 m/z and mass resolution of 15000 (fwhm). The absorption spectra in the UV–visible region were measured on a Thermo Scientific Evolution 600 UV–vis spectrophotometer using quartz SUPRAXIL cuvettes, light path 10 mm. The oxazolones 1a–1o used as starting materials were synthesized according to published methods.[104−113]

Irradiation Setup

The irradiation setup consists of a round-bottom flask irradiated by either a printed circuit board (PCB) formed by 24 LEDs bulbs (Topbright) of a 10 mm diameter, each irradiating at 465 nm, or a commercial Kessil lamp irradiating at 456 nm. The LEDs are serially connected in blocks of 6. The output power per LED unit (blue, 465 nm) is 250 kmcd. The optical output power of the PCB of LEDs measured with a photometer (PM100D, Thorlabs) was 1 W, so the maximal power provided by the PCB is 24 W. The PCB (dimensions: 7 cm × 6 cm) and the flask are placed inside a custom-built setup for fixing the light source and the sample container and dissipate the excess heating. A concave mirror is placed in front of the PCB to maximize the light that irradiates the LEDs. The Kessil lamp is the PR160L-456 nm model, with a maximal power of 40 W. The intensity of the lamp can be tuned, and different powers were tested. Those specified in each case gave the maximum yield.

X-ray Crystallography

Single crystals of 3g, 3h, 4b, and 7n of suitable quality for X-ray diffraction measurements were grown by slow diffusion of n-pentane into CH2Cl2 solutions of the crude product at −18 °C for several weeks, while those of 3m were obtained by slow evaporation of a solution of the product in CH2Cl2. A single crystal was mounted in each case at the end of a quartz fiber in a random orientation. The crystal was fixed to the fiber with epoxy resin (3g) or covered with perfluorinated oil and placed under a cold stream of N2 gas (3h, 3m, 4b, 7n). The data collections were performed at 293(2) K on an Oxford Diffraction Xcalibur Sapphire3 diffractometer (3g) or at 100(2) K on Bruker D8 Venture (3h, 3m) or Bruker APEX CCD (4b, 7n) diffractometers using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). A hemisphere of data was collected based on ω-scan and φ-scan runs. The diffraction frames were integrated using the programs CrysAlis RED[114] and SAINT,[115] and the integrated intensities were corrected for absorption with SADABS.[116] The structures were solved and developed by Fourier methods.[117] All non-hydrogen atoms were refined with anisotropic displacement parameters. The H atoms were placed at idealized positions and treated as riding atoms. Each H atom was assigned an isotropic displacement parameter equal to 1.2 times the equivalent isotropic displacement parameter of its parent atom. The structures were refined to Fo2, and all reflections were used in the least-squares calculations.[118] CCDC 1912941 (3g), 1912942 (7n), 1958992 (3h), 1958993 (3m), and 1999650 (4b) contains the supplementary crystallographic data for this paper and can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.

General Procedure for the Synthesis of (Z)-2-Phenyl-4-aryliden-5(4H)-thiazolones 2a–2o

The synthesis of the thiazolones 2a–2o has been carried out following the same experimental procedure as that reported by Rao and Filler,[46] which in turn is based in the original work of Behringer et al.[63,64] Thiazolones 2a–2c have been previously described, although 2b was prepared using a different method.[65,66] Thiazolones 2e, 2f, 2g, 2h, and 2j appear on Scifinder, but either no references are associated with their synthesis, or no details of their preparation and characterization can be found in the literature associated. Therefore, we present here the full synthesis and characterization of thiazolones 2d–2o.

(Z)-4-(4-Fluorobenzylidene)-2-phenyl-5(4H)-thiazolone 2d

The oxazolone 1d (2.5 g, 9.3 mmol), thioacetic acid (2.0 mL, 28.4 mmol) and NEt3 (0.1 mL) were heated in an oil bath at 70 °C while stirred for 18 h. During this time the oxazolone dissolved, giving a dark solution, and after some minutes a deep-colored solid precipitated. After the reaction time the mixture was left to reach room temperature and ethanol (30 mL) was added to complete the precipitation. The yellow solid thus formed was filtered, washed thoroughly with ethanol (120–150 mL) until the characteristic smell of thioacetic acid disappeared, dried by suction, and characterized as 2d. Obtained: 1.64 g (62% yield). 1H NMR (CD2Cl2, 300.13 MHz): δ = 8.30 (dd, 2H, H2/H6, C6H4F, 3JHH = 8.7 Hz, 4JHF = 5.7 Hz), 8.00 (d, 2H, Ho, Ph, 3JHH = 6.5 Hz), 7.61–7.50 (m, 3H, Hp+2Hm,Ph), 7.18 (t, 2H, H3/H5, 3JHH≈ 3JHF = 8.7 Hz), 7.17 (s, 1H, Hvinyl). 19F NMR (CD2Cl2, 282.4 MHz): δ = −107.41 (tt, 3JFH = 8.7 Hz, 4JFH = 3.1 Hz). 13C{1H} NMR (CD2Cl2, 75.5 MHz): δ = 194.7 (CO), 167.6 (NCS), 165.0 (d, C4F, 1JCF = 254 Hz), 146.4 (=C), 136.0 (d, 2CH, C2/C6, 3JFC = 8.7 Hz), 133.9 (C, Ci, Ph), 133.3 (CH, Cp, Ph), 130.8 (d, C, C1, C6H4F, 4JFC = 3.3 Hz), 130.0 (d, CH, Cvinyl, 5JFC = 1.7 Hz), 129.6 (2CH, Cm, Ph), 128.8 (2CH, Co, Ph), 116.7 (d, 2CH, C3/C5, C6H4F, 2JFC = 22.0 Hz). HRMS (ESI+) [m/z]: calcd for [C16H10FNNaOS]+ = [M + Na]+, 306.0359; found, 306.0349. IR (ν, cm–1): 1682 (CO, vs).

(Z)-4-(4-Chlorobenzylidene)-2-phenyl-5(4H)-thiazolone 2e

Thiazolone 2e was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1e (2.5 g, 8.8 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2e as a deep yellow solid. Obtained: 1.55 g (59% yield). 1H NMR (CD2Cl2, 300.13 MHz): δ = 8.25 (AA′BB′ spin system, 2H, H3/H5, C6H4Cl,), 8.04 (dd, 2H, Ho, Ph, 3JHH = 8.2 Hz, 4JHH = 1.5 Hz), 7.64–7.55 (m, 3H, Hp+2Hm,Ph), 7.48 (AA′BB′ spin system, 2H, H2/H6, C6H4Cl), 7.18 (s, 1H, Hvinyl). 13C{1H} NMR (CD2Cl2, 75.5 MHz): δ = 194.1 (CO), 167.5 (NCS), 146.4 (=C), 137.3 (C, C4, C6H4Cl), 134.2 (2CH, C3/C5, C6H4Cl), 133.3 (C1, C6H4Cl), 132.9 (CH, Cp, Ph), 132.4 (Ci, Ph), 129.2 (CH, Cvinyl), 129.2 (2CH, C2/C6, C6H4Cl), 129.0 (2CH, Cm, Ph), 128.3 (2CH, Co, Ph). HRMS (ESI+) [m/z]: calcd for [C16H10ClNNaOS]+ = [M + Na]+, 322.0064; found, 322.0053.

(Z)-4-(4-Bromobenzylidene)-2-phenyl-5(4H)-thiazolone 2f

Thiazolone 2f was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1f (2.5 g, 7.6 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2f as a deep yellow solid. Obtained: 1.19 g (45% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.13 (d, 2H, H3 + H5, C6H4Br, 3JHH = 8.5 Hz), 8.01 (d, 2H, Ho, Ph, 3JHH = 6.7 Hz), 7.61 (d, 2H, H2 + H6, C6H4Br, 3JHH = 8.5 Hz), 7.57–7.51 (m, 3H, Hp + 2Hm, Ph), 7.16 (s, 1H, Hvinyl). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.5 (CO), 167.7 (NCS), 146.7 (=C), 134.5 (2CH, C3 + C5, C6H4Br), 133.5 (C1, C6H4Br), 133.0 (CH, Cp, Ph), 132.8 (Ci, Ph), 132.4 (2CH, C2 + C6, C6H4Br), 129.8 (CH, Cvinyl), 129.2 (2CH, Cm, Ph), 128.5 (2CH, Co, Ph), 126.3 (C4, C-Br, C6H4Br). HRMS (ESI+) [m/z]: calcd for [C16H10BrNNaOS]+ = [M + Na]+, 365.9559; found, 365.9551.

(Z)-4-(4-Nitrobenzylidene)-2-phenyl-5(4H)-thiazolone 2g

Thiazolone 2g was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1g (2.5 g, 8.5 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2g as a deep yellow solid. Obtained: 1.02 g (38% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.45 (AA′BB′ spin system, 2H, H3/H5, C6H4NO2), 8.35 (AA′BB′ spin system, 2H, H2/H6, C6H4NO2), 8.07 (d, 2H, Ho, Ph, 3JHH = 7.2 Hz), 7.66–7.57 (m, 3H, Hp+2Hm,Ph), 7.24 (s, 1H, Hvinyl). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 195.3 (CO), 169.1 (NCS), 148.4 (C4, C6H4NO2), 139.7 (C1, C6H4NO2), 133.5 (CH, Cp, Ph), 133.3 (2CH, C3/C5, C6H4NO2), 129.2 (2CH, Cm, Ph), 128.6 (2CH, Co, Ph), 127.0 (CH, Cvinyl), 123.9 (2CH, C2/C6, C6H4NO2). Due to low solubility some quaternary 13C signals (Ci of Ph and = C of the arylidene fragment) were missing. HRMS (ESI+) [m/z]: calcd for [C16H10N2NaO3S]+ = [M + Na]+, 333.0310; found, 333.0317. IR (ν, cm–1): 1696 (vs).

(Z)-4-(4-Trifluoromethylbenzylidene)-2-phenyl-5(4H)-thiazolone 2h

Thiazolone 2h was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1h (2.5 g, 7.9 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2h as a pale-yellow solid. Obtained: 1.84 g (70% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.34 (AA′BB′ spin system, 2H, H2/H6, C6H4CF3), 8.01 (dd, 2H, Ho, Ph, 3JHH = 8.2 Hz, 4JHH = 1.5 Hz), 7.72 (AA′BB′ spin system, 2H, H3/H5, C6H4CF3), 7.60–7.50 (m, 3H, Hp+2Hm,Ph), 7.19 (s, 1H, Hvinyl). 19F NMR (CDCl3, 282.4 MHz): δ = −62.97 (s). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.4 (CO), 168.9 (NCS), 147.7 (=C), 137.1 (q, C1, C6H4CF3,5JCF = 1.4 Hz), 133.3 (CH, Cp, Ph), 133.2 (Ci, Ph), 133.1 (2CH, C2/C6, C6H4CF3), 132.2 (q, C, C4, C6H4CF3,2JCF = 43 Hz), 129.2 (2CH, Cm, Ph), 128.7 (CH, Cvinyl), 128.6 (2CH, Co, Ph), 125.8 (2CH, C3/C5, C6H4CF3,3JCF = 3.8 Hz), 120.4 (q, CF3, 1JCF = 272 Hz). Anal. Calcd for C17H10F3NOS: C, 61.26; H, 3.02; N, 4.20; S, 9.62. Found: C, 60.94; H, 3.12; N, 3.91; S, 9.93.

(Z)-4-(2-Methoxybenzylidene)-2-phenyl-5(4H)-thiazolone 2i

Thiazolone 2i was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1i (2.5 g, 8.9 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2i as a pale-yellow solid. Obtained: 0.80 g (30% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.95 (d, 1H, H6, C6H4OMe, 3JHH = 7.8 Hz), 8.02 (d, 2H, Ho, Ph, 3JHH = 6.5 Hz), 7.90 (s, 1H, Hvinyl), 7.57–7.42 (m, 4H, Hp(Ph) + 2Hm(Ph) + H4/H5 (C6H4OMe)), 7.12 (t, 1H, H4/H5, C6H4OMe, 3JHH = 7.6 Hz), 6.94 (d, 1H, H3, C6H4OMe, 3JHH = 8.3 Hz), 3.92 (s, 3H, OMe). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.6 (CO), 165.9 (NSC), 160.1 (C2, C-OMe, C6H4OMe), 145.7 (=C), 133.6 (Ci, Ph), 133.5 (CH, C6, C6H4OMe), 133.2 (CH, C4/C5, C6H4OMe), 132.4 (CH, Cp, Ph), 128.9 (2CH, Cm, Ph), 128.2 (2CH, Co, Ph), 125.4 (CH, Cvinyl), 122.9 (C1, C6H4OMe), 121.0 (CH, C4/C5, C6H4OMe), 110.8 (CH, C3, C6H4OMe), 55.7 (OMe). HRMS (ESI+) [m/z]: calcd for [C17H13NNaO2S]+ = [M + Na]+, 318.0559; found, 318.0555.

(Z)-4-(2-Chlorobenzylidene)-2-phenyl-5(4H)-thiazolone 2j

Thiazolone 2j was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1j (2.5 g, 8.8 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2j as a yellow solid. Obtained: 0.98 g (36% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.95 (dd, 1H, H6, C6H4Cl, 3JHH = 7.8 Hz, 4JHH = 2.0 Hz), 8.01 (m, 2H, Ho, Ph), 7.75 (s, 1H, Hvinyl), 7.62–7.34 (m, 6H, Hp(Ph) + 2Hm(Ph) + H3/H4/H5 (C6H4Cl)). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.2 (CO), 168.3 (NSC), 147.2 (=C), 137.5, 131.8 (Ci/C2, C6H4Cl), 133.9 (CH, C6, C6H4Cl), 133.3 (Ci, Ph), 133.0 (CH, Cp, Ph), 131.7, 130.0, 127.1 (CH, C3/C4/C5, C6H4Cl), 129.0 (2CH, Cm, Ph), 128.4 (2CH, Co, Ph), 126.0 (CH, Cvinyl). HRMS (ESI+) [m/z]: calcd for [C16H10ClNNaOS]+ = [M + Na]+, 322.0064; found, 322.0072.

(Z)-4-(2-Bromobenzylidene)-2-phenyl-5(4H)-thiazolone 2k

Thiazolone 2k was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1k (2.5 g, 7.6 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2k as a deep yellow solid. Obtained: 1.02 g (39% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.92 (dd, 1H, H3, C6H4Br, 3JHH = 8.0 Hz, 4JHH = 1.7 Hz), 8.01 (dd, 2H, Ho, Ph, 3JHH = 8.2 Hz, 4JHH = 1.5 Hz), 7.70 (s, 1H, Hvinyl), 7.68 (dd, 1H, H6, C6H4Br, 3JHH = 8.0 Hz, 4JHH = 1.2 Hz), 7.60–7.45 (m, 4H, Hp + 2Hm (Ph) + H4(C6H4Br)), 7.30 (td, 1H, H5, C6H4Br, 3JHH = 8.0 Hz, 4JHH = 1.7 Hz). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.1 (CO), 168.3 (NCS), 147.2 (=C), 134.0 (CH, C3, C6H4Br), 133.4 (CH, C5/C6, C6H4Br), 133.3 (Ci, Ph), 133.0 (CH, Cp, Ph), 131.9 (CH, C5/C6, C6H4Br), 129.0 (2CH, Co, Ph), 128.8 (CH, Cvinyl), 128.4 (2CH, Cm, Ph), 128.3 (2 overlapped carbons, C1+C2, C6H4Br), 127.7 (CH, C4, C6H4Br). HRMS (ESI+) [m/z]: calcd for [C16H10BrNNaOS]+ = [M + Na]+, 365.9559; found, 365.9548.

(Z)-4-(3,4-Dimethoxybenzylidene)-2-phenyl-5(4H)-thiazolone 2l

Thiazolone 2l was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1l (2.5 g, 8.1 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2l as a deep orange solid. Obtained: 1.59 g (60% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.29 (s, 1H, H2, C6H3), 7.97 (d, 1H, Ho, Ph, 3JHH = 7.2 Hz), 7.60 (d, 1H, H6, C6H3, 3JHH = 8.4 Hz), 7.55–7.48 (m, 3H, 2Hm + Hp(Ph)), 7.20 (s, 1H, Hvinyl), 6.94 (d, 1H, H5, C6H3, 3JHH = 8.4 Hz), 4.02 (s, 3H, OMe), 3.97 (s, 3H, OMe). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.4 (CO), 165.1 (NCS), 152.3, 149.1 (2C, C3+C4, C6H3), 144.5 (=C), 133.6 (Ci, Ph), 132.3 (CH, C6, C6H3), 131.7 (CH, Cvinyl), 129.0 (2CH, Cm,Ph), 128.9 (CH, Cp, Ph), 127.8 (2CH, Co, Ph), 127.0 (C, C1, C6H3), 114.5 (CH, C2, C6H3), 110.9 (CH, C5, C6H3), 56.0 (OCH3), 55.8 (OCH3). HRMS (ESI+) [m/z]: calcd for [C18H15NNaO3S]+ = [M + Na]+, 348.0665; found, 348.0659. IR (ν, cm–1): 1704 (vs), 1677.

(Z)-4-(3,4-Dimethylbenzylidene)-2-phenyl-5(4H)-thiazolone 2m

Thiazolone 2m was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1m (2.5 g, 9.0 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2m as a yellow solid. Obtained: 1.18 g (44% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.09 (d, 1H, H6, C6H3, 3JHH = 8.0 Hz), 8.05–8.02 (m, 3H, H5 (C6H3)+ 2Ho(Ph)), 7.59–7.52 (m, 3H, Hp + 2Hm, Ph), 7.29 (s, 1H, H2, C6H3), 7.23 (s, 1H, Hvinyl), 2.37 (s, 3H, Me, C6H3(Me)2), 2.36 (s, 3H, Me, C6H3(Me)2). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.7 (CO), 165.7 (NCS), 145.5 (=C), 141.2 (C, C6H3), 137.2 (C, C6H3), 134.6 (CH, C5, C6H3), 133.6 (Ci, Ph), 132.4 (CH, Cvinyl), 131.9 (CH, Cp, Ph), 131.5 (C, C6H3), 131.0 (CH, C6, C6H3), 130.4 (CH, C2, C6H3), 128.9 (2CH, Cm, Ph), 128.1 (2CH, Co, Ph), 20.2 (CH3), 19.9 (CH3). HRMS (ESI+) [m/z]: calcd for [C18H15NNaOS]+ = [M + Na]+, 316.0767; found, 316.0771. IR (ν, cm–1): 1687 (vs), 1652.

(Z)-4-(3,4-Dichlorobenzylidene)-2-phenyl-5(4H)-thiazolone 2n

Thiazolone 2n was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1n (2.5 g, 7.9 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2n as a yellow solid. Obtained: 1.74 g (66% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.49 (d, 1H, H2, C6H3Cl2, 4JHH = 1.9 Hz), 8.06–8.02 (m, 3H, H5/H6(C6H3Cl2) + 2Ho(Ph)), 7.63–7.55 (m, 4H, H5/H6(C6H3Cl2) + 2Hm + Hp (Ph)), 7.12 (s, 1H, Hvinyl). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.1 (CO), 168.5 (NCS), 147.1 (=C), 145.1 (C, C6H3Cl2), 135.3 (C, C6H3Cl2), 134.2 (CH, C6, C6H3Cl2), 133.7 (2C overlapped, Ci (Ph) + C (C6H3Cl2)), 133.1 (CH, C5, C6H3Cl2), 131.9 (CH, C2, C6H3Cl2), 130.8 (CH, Cp,Ph), 129.1 (2CH, Co,Ph), 128.4 (2CH, Cm,Ph), 127.8 (CH, Cvinyl). HRMS (ESI+) [m/z]: calcd for [C16H9Cl2NNaOS]+ = [M + Na]+, 355.9665; found, 355.9664. IR (ν, cm–1): 1699 (vs), 1683.

(Z)-4-(3,4-Difluorobenzylidene)-2-phenyl-5(4H)-thiazolone 2o

Thiazolone 2o was obtained following the same experimental procedure than the described for 2d. Therefore, oxazolone 1o (2.5 g, 8.8 mmol) was reacted with thioacetic acid (2 mL) and NEt3 (0.1 mL) for 18 h at 70 °C to give 2o as a yellow solid. Obtained: 0.98 g (37% yield). 1H NMR (CDCl3, 300.13 MHz): 8.43 (ddd, 1H, H2, C6H3F2, 3JFH = 11.7 Hz, 4JFH = 8.0 Hz, 4JHH = 1.9 Hz), 8.04 (d, 2H, Ho, Ph, 3JHH = 6.7 Hz), 7.81 (m, 1H, H5, C6H3F2), 7.63–7.54 (m, 3H, Hp + 2Hm, Ph), 7.28 (t, 1H, H6, C6H3F2, 3JHH ≈ 4JFH = 8.5 Hz), 7.15 (s, 1H, Hvinyl). 19F NMR (CDCl3, 282.40 MHz): δ = −131.30 (dddd, 1F, F4, 3JFF = 21.0 Hz, 3JFH = 14.1 Hz, 4JFH = 8.0 Hz, 4JFH = 6.0 Hz), −135.95 (ddd, 1F, F3, 3JFF = 21.0 Hz, 3JFH = 14.1 Hz, 4JFH = 6.0 Hz). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 194.2 (CO), 168.1 (NCS), 152.2 (dd, C, C3/C4, C6H3F2, 1JCF = 272 Hz, 2JCF = 13.3 Hz), 150.2 (dd, C, C3/C4, C6H3F2, 1JCF = 272 Hz, 2JCF = 13.3 Hz), 146.5 (=C), 133.2 (C, Ci, Ph), 133.0 (CH, Cp, Ph), 131.0 (dd, C, C1, C6H3F2, 3JCF = 4.1 Hz), 130.2 (dd, CH, C5, C6H3F2, 2JCF = 6.6 Hz, 3JCF = 3.4 Hz), 129.1 (2CH, Cm, Ph), 128.4 (2CH, Co, Ph), 128.3 (CH, Cvinyl), 121.1 (d, CH, C2, C6H3F2, 2JCF = 18.7 Hz), 117.7 (d, CH, C6, C6H3F2, 2JCF = 17.8 Hz). HRMS (ESI+) [m/z]: calcd for [C16H10F2NOS]+ = [M + H]+, 302.0445; found, 302.0446.

General Procedure for the [2 + 2]-Photocycloaddition of 4-Arylidene-2-phenyl-5(4H)-thiazolones 2: Synthesis of Cyclobutanes 3a–3o

A solution of the 4-arylidene-2-phenyl-5(4H)-thiazolones 2a–2o (∼1 mmol) in 10 mL of CH2Cl2 was irradiated for 24–72 h with the blue light (465 nm) provided by the PCB of 24 LEDs while stirred at room temperature. The progress of the reaction was followed by 1H NMR. After 72 h, the conversion of thiazolones 2a–2o into cyclobutanes 3a–3o was complete (exceptions are indicated). The solvent was then evaporated to dryness, and the yellow solid residue was characterized by NMR as the cyclobutanes 3a–3o. In almost all cases, the ε-isomer appeared as the major isomer (>90% molar ratio) with minor amounts (<10%) of other isomers (exceptions are indicated). For that reason, only the ε-isomer is fully characterized.

Numbering of Cyclobutanes 3a–3o, Exemplified with 3a

2,6,9,12-Tetraphenyl-3,10-dithia-1,8-diazadispiro[4.1.47.15]-dodeca-1,8-diene-4,11-dione 3a

Following the general method, thiazolone 2a (300 mg, 1.13 mmol) was reacted in CH2Cl2 with blue light for 24 h to give 3a as a yellow solid. Compound 3a was recrystallized in a mixture CH2Cl2/n-pentane, the ε-isomer was obtained selectively. Obtained: 245.4 mg (82% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.90 (m, 2H, Ho, NCS-Ph), 7.54–7.48 (m, 5H, Hm, Hp, NCS-Ph; Ho, Ph), 7.20 – 7.12 (m, 3H, Hm, Hp, Ph), 4.71 (s, 1H, CH,H-C(6,12)). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 208.0 (SC = O, C4,11), 164.9 (SC = N, C2,9), 133.6 (Ci, Ph), 132.7 (Ci, Ph), 132.3 (Cp, CH, Ph), 131.1 (CH, Ph), 129.0 (CH, Ph), 128.5 (Co, CH, C2,9-Ph), 128.2 (Cp, CH, Ph), 128.0 (CH, Ph), 91.3 (Cq, C5,7), 58.5 (CH, C6,12). HRMS (ESI+) [m/z]: calcd for [C32H23N2O2S2]+=[M + H]+, 531.1195, found 531.1203.

2,9-Diphenyl-6,12-di-p-tolyl-3,10-dithia-1,8-diazadispiro[4.1.47.15]-dodeca-1,8-diene-4,11-dione 3b

Following the general method, thiazolone 2b (300 mg, 1.07 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3b as a yellow solid. Cyclobutane 3b was obtained as a mixture of two isomers in 90:10 molar ratio. Obtained: 300 mg (100% yield). Only the major ε-isomer was fully characterized. 1H NMR (CD2Cl2, 300.13 MHz): δ = 7.98 (m, 2H, Ho, Ph), 7.59 (m, 3H, Hm, Hp, Ph), 7.41 (AA′BB′ spin system, 2H, Ho, C6H4), 7.02 (AA′BB′ spin system, 2H, Hm, C6H4), 4.65 (s, 1H, H-C6,12), 2.21 (s, 3H, CH3). 13C{1H} NMR (CD2Cl2, 75.5 MHz): δ = 207.8 (SC = O, C4,11), 164.6 (SC = N, C2,9), 137.9 (C-CH3),133.3 (Ci, Ph), 132.2 (Cp, Ph), 130.6 (2C, Cm, C6H4), 129.6 (Ci, C6H4), 128.9 (2C, Cm, Ph), 128.4 (2C, Co, C6H4), 128.3 (2C, Co, Ph), 91.2 (Cq, C5,7), 58.1 (CH, C6,12), 20.7 (CH3). HRMS (ESI+) [m/z]: calcd for [C34H26N2NaO2S2]+ = [M + Na]+, 581.1333; found, 581.1329.

6,12-Bis(4-methoxyphenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15]dodeca-1,8-diene-4,11-dione 3c

Following the general method, thiazolone 2c (300 mg, 1.01 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3c as a yellow solid. Cyclobutane 3c was obtained as a mixture of four isomers in 59:25:9:7 molar ratio. Obtained: 300 mg (100% yield). Only the major ε-isomer was fully characterized. 1H NMR (CD2Cl2, 300.13 MHz): δ = 7.99 (m, 2H, Ho, Ph), 7.60–7.58 (m, 3H, Hm, Hp, Ph), 7.52 (AA′BB′ spin system, 2H, Ho, C6H4), 6.75 (AA′BB′ spin system, 2H, Hm, C6H4), 4.64 (s, 1H, H-C6,12), 3.69 (s, 3H, -OCH3). 13C{1H} NMR (CD2Cl2, 75.5 MHz): δ = 207.8 (SC = O, C4,11), 164.6 (SC = N, C2,9), 159.4 (C-OCH3),133.4 (Ci, Ph), 132.3 (2C, Co, C6H4), 131.9 (Cp, Ph), 128.9 (2C, Cm, Ph), 128.2 (2C, Co, Ph), 124.7 (Ci, C6H4), 113.0 (2C, Cm, C6H4), 91.7 (Cq, C5,7), 57.9 (CH, C6,12), 55.0 (OCH3). HRMS (ESI+) [m/z]: calcd for [C34H26N2NaO4S2]+ = [M + Na]+, 613.1232; found, 613.1237.

6,12-Bis(4-fluorophenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15]dodeca-1,8-diene-4,11-dione 3d

Following the general method, thiazolone 2d (300 mg, 1.06 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3d as a yellow solid. Cyclobutane 3d was obtained as a mixture of two isomers in 91:9 molar ratio. Obtained: 298 mg (99% yield). Only the major ε-isomer was fully characterized. 1H NMR (CD2Cl2, 300.13 MHz): δ = 7.97 (m, 2H, Ho, Ph), 7.63–7.55 (m, 2H, Ho, C6H4 + 2H, Hm, Ph + 1H, Hp, Ph), 6.92 (t, 2H, Hm, C6H4, 3JHH = 3JFH = 8.73 Hz), 4.69 (s, 1H, H-C6,12). 13C{1H} NMR (CD2Cl2, 75.5 MHz): δ = 207.3 (SC = O, C4,11), 165.5 (SC = N, C2,9), 162.5 (d, C-F, 1JFC = 247 Hz), 133.2 (Ci, C6H4), 132.9 (d, 2C, Co, C6H4,3JFC = 8.3 Hz), 132.5 (Cp, Ph), 129.0 (2C, Cm, Ph), 128.4 (Ci, Ph), 128.2 (2C, Co, Ph), 114.6 (d, 2C, Cm, C6H4,2JFC = 21.3 Hz), 90.9 (Cq, C5,7), 57.4 (CH, C6,12). 19F NMR (CD2Cl2, 282.4 MHz) δ = −114.13 (tt, 3JFH = 8.68 Hz, 4JFH = 3.36 Hz). HRMS (ESI+) [m/z]: calcd for [C32H20F2N2NaO2S2]+ = [M + Na]+, 589.0826; found, 589.0812.

6,12-Bis(4-chlorophenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15]dodeca-1,8-diene-4,11-dione 3e

Following the general method, thiazolone 2e (300 mg, 1.00 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3e as a yellow solid. Cyclobutane 3e was obtained as a mixture of two isomers in a 96:4 molar ratio. Obtained: 255 mg (85% yield). Only the major ε-isomer was fully characterized. 1H NMR (CDCl3, 500.13 MHz): δ = 7.89 (m, 2H, Ho, Ph), 7.59–7.52 (m, 3H, Hm+Hp, Ph), 7.47 (m, 2H, Ho, C6H4), 7.14 (m, 2H, Hm, C6H4), 4.63 (s, 1H, H-C6,12). 13C{1H} NMR (CDCl3, 125.76 MHz): δ = 207.3 (SC = O, C4,11), 165.6 (SC = N, C2,9), 134.3 (C-Cl, C6H4), 133.2 (Ci, Ph), 132.5 (Cp, Ph), 132.4 (2C, Co, C6H4), 130.7 (Ci, C6H4), 129.0 (2C, Cm, Ph), 128.3 (2C, Co, Ph), 128.1 (2C, Cm, C6H4), 90.7 (Cq, C5,7), 57.5 (CH, C6,12). HRMS (ESI+) [m/z]: calcd for [C32H20Cl2N2NaO2S2]+ = [M + Na]+, 621.0241; found, 621.0233.

6,12-Bis(4-bromophenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15]dodeca-1,8-diene-4,11-dione 3f

Following the general method, thiazolone 2f (300 mg, 0.87 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3f as a yellow solid. Cyclobutane 3f was obtained as a mixture of two isomers in 83:17 molar ratio. Obtained: 276 mg (92% yield). Only the major ε-isomer was fully characterized. 1H NMR (CDCl3, 300.13 MHz): δ = 7.89 (m, 2H, Ho, Ph), 7.57–7.51 (m, 3H, Hm + Hp, Ph), 7.41 (m, 2H, Ho, C6H4), 7.30 (m, 2H, Hm, C6H4), 4.63 (s, 1H, H-C6,12). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 207.3 (SC = O, C4,11), 165.8 (SC = N, C2,9), 133.3 (Ci, Ph), 132.8 (2C, Co, C6H4), 132.6 (Cp, Ph), 131.4 (Ci, C6H4), 131.2 (2C, Cm, C6H4), 129.2 (2C, Cm, Ph), 128.4 (2C, Co, Ph), 122.8 (Br-Cp, C6H4), 90.7 (Cq, C5,7), 57.7 (CH, C6,12). Anal. Calcd for C16H10BrNOS: C, 55.83; H, 2.93; N, 4.07; S, 9.31. Found: C, 56.18; H, 2.63; N, 4.08; S, 9.67.

6,12-Bis(4-nitrophenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15]dodeca-1,8-diene-4,11-dione 3g

Following the general method, thiazolone 2g (300 mg, 0.94 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3g as a yellow solid. Cyclobutane 3g was obtained as a single isomer (ε-isomer). Obtained: 298 mg (100% yield). 1H NMR (CD2Cl2, 300.13 MHz): δ = 8.06 (m, 2H, Hm, C6H4), 7.95 (m, 2H, Ho, Ph), 7.77 (m, 2H, Ho, C6H4), 7.65–7.56 (m, 3H, Hp + Hm, Ph), 4.84 (s, 1H, H-C6,12). 13C{1H} NMR (CD2Cl2, 75.5 MHz): δ = 206.5 (SC = O, C4,11), 167.0 (SC = N, C2,9), 147.7 (C6H4, C-NO2), 139.2 (Ci, C6H4), 132.9 (Cp, Ph), 132.7 (Ci, Ph), 131.9 (2C, Co, C6H4), 129.1 (2C, Cm, Ph), 128.3 (2C, Co, Ph), 122.9 (2C, Cm, C6H4), 89.7 (Cq, C5,7), 57.1 (CH, C6,12). HRMS (ESI+) [m/z]: calcd for [C32H20N4NaO6S2]+ = [M + Na]+, 643.0716; found, 643.0708.

6,12-Bis(4-trifluoromethylphenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro[4.1.47.15] dodeca-1,8-diene-4,11-dione 3h

Following the general method, thiazolone 2h (300 mg, 0.90 mmol) was reacted in CH2Cl2 with blue light for 72 h to give a maximal conversion of 3h of 80% as a single isomer (ε-isomer). Further irradiation of the solution did not improved the conversion. Obtained: 241 mg. The remaining thiazolone 2h proved to be difficult to be separated. 1H NMR (CDCl3, 500.13 MHz): δ = 7.89 (m, 2H, Ho, Ph), 7.63 (m, 2H, Ho, C6H4), 7.60–7.53 (m, 3H, Hp + Hm, Ph), 7.44 (m, 2H, Hm, C6H4), 4.75 (s, 1H, H-C6,12). 13C{1H} NMR (CDCl3, 125.7 MHz): δ = 207.1 (SC = O, C4,11), 166.3 (SC = N, C2,9), 136.2 (Ci, C6H4), 133.1 (Ci, Ph), 132.8 (Cp, Ph), 131.4 (2C, Co, C6H4), 130.5 (q, C-CF3, 2JCF = 66.6 Hz), 129.3 (2C, Cm, Ph), 128.4 (2C, Co, Ph), 125.0 (q, 2C, Cm, C6H4, 3JCF = 3.7 Hz), 124.0 (q, CF3, 1JCF = 272.2 Hz), 90.5 (Cq, C5,7), 57.7 (CH, C6,12). 19F NMR (CDCl3, 282 MHz) δ = −62.72 (s, CF3). HRMS (ESI+) [m/z]: calcd for [C34H20F6N2NaO2S2]+ = [M + Na]+, 689.0752; found, 689.0768.

6,12-Bis(2-chlorophenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15]dodeca-1,8-diene-4,11-dione 3j

Following the general method, thiazolone 2j (300 mg, 1.00 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3j as a yellow solid. Cyclobutane 3j was obtained as the mixture of two isomers in 71:29 molar ratio. Obtained: 285 mg (95% yield). Only the major ε-isomer was fully characterized. 1H NMR (CDCl3, 500.13 MHz): δ = 8.19 (dd, 1H, H6, C6H4, 3JHH = 7.0 Hz, 4JHH = 2.3 Hz), 7.87 (m, 2H, Ho, Ph), 7.58–7.46 (m, 3H, Hm+Hp, Ph, overlapped with minor isomer), 7.24 (dd, 1H, H3, C6H4, 3JHH = 7.0 Hz, 4JHH = 1.9 Hz), 7.06 (td, 2H, H4, H5, C6H4, 3JHH = 7.0 Hz, 4JHH = 1.9 Hz), 5.54 (s, 1H, H-C6,12). 13C{1H} NMR (CDCl3, 125.7 MHz): δ = 206.3 (SC = O, C4,11), 165.6 (SC = N, C2,9), 134.9 (C1, C6H4), 134.0 (C6, C6H4), 133.4 (Ci, Ph), 132.3 (Cp, Ph), 130.4 (C2, C6H4), 129.2, 125.8 (2C, C4, C5, C6H4), 129.1 (C3, C6H4), 128.9 (2C, Cm, Ph), 128.2 (2C, Co, Ph), 90.4 (Cq, C5,7), 53.0 (CH, C6,12). HRMS (ESI+) [m/z]: calcd for [C32H20Cl2N2NaO2S2]+ = [M + Na]+, 621.0241; found, 621.0238.

6,12-Bis(2-bromophenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15] dodeca-1,8-diene-4,11-dione 3k

Following the general method, thiazolone 2k (300 mg, 0.87 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3k as a yellow solid. Cyclobutane 3k was obtained as the mixture of two isomers in 65:35 molar ratio. Obtained: 295 mg (98% yield). In this case, well-separated peaks were observed for the two isomers, allowing their full characterization. Major isomer (ε-isomer) 1H NMR (CDCl3, 500.13 MHz): δ = 8.32 (dd, 1H, H6, C6H4, 3JHH = 8.1 Hz, 4JHH = 1.7 Hz), 7.87 (m, 2H, Ho, Ph), 7.58–7.48 (m, 3H, Hp+Hm, Ph; overlapped with minor isomer), 7.43 (dd, 1H, H3, C6H4, 3JHH = 7.9 Hz, 4JHH = 1.2 Hz), 7.14 (td, 1H, H5, C6H4, 3JHH = 7.8 Hz, 4JHH = 1.3 Hz), 6.97 (td, 1H, H4, C6H4, 3JHH = 7.8 Hz, 4JHH = 1.7 Hz), 5.62 (s, 1H, H-C6,12). 13C{1H} NMR (CDCl3, 125.76 MHz): δ = 206.2 (SC = O, C4,11), 165.6 (SC = N, C2,9), 134.5 (C6, C6H4), 133.4 (Ci, Ph),132.5 (C3, C6H4), 132.3 (Cp, Ph), 132.1 (Ci, C6H4), 129.5 (C4, C6H4), 128.9 (2C, Cm, Ph; overlapped with minor isomer), 128.2 (2C, Co, Ph), 126.4 (C5, C6H4), 125.9 (Br-C2, C6H4), 90.5 (Cq, C5,7), 55.4 (CH, C6,12). Minor isomer (α-isomer) 1H NMR (CDCl3, 500.13 MHz): δ = 8.62 (dd, H6, C6H4, 3JHH = 8.0 Hz, 4JHH = 2.2 Hz), 7.96 (m, Ho, Ph), 7.58–7.48 (m, Hp+Hm, Ph; overlapped with major isomer), 7.46 (dd, 1H, H3, C6H4, 3JHH = 8.0 Hz, 4JHH = 1.1 Hz), 7.35 (td, 1H, H5, C6H4, 3JHH = 7.7 Hz, 4JHH = 1.3 Hz), 7.09 (td, 1H, H4, C6H4, 3JHH = 7.8 Hz, 4JHH = 1.7 Hz), 5.91 (s, 1H, H-C6,12). 13C{1H} NMR (CDCl3, 125.76 MHz): δ = 205.8 (SC = O, C4,11), 164.9 (SC = N, C2,9), 134.0 (C6, C6H4), 133.5 (Ci, Ph),133.3 (Ci, C6H4), 132.6 (C3, C6H4), 132.3 (Cp, Ph), 129.5 (C4, C6H4), 128.9 (2C, Cm, Ph, overlapped), 128.5 (2C, Co, Ph), 127.0 (C5, C6H4), 125.4 (Br-C2, C6H4), 88.7 (Cq, C5,7), 54.9 (CH, C6,12). Anal. Calcd for C16H10BrNOS: C, 55.83; H, 2.93; N, 4.07; S, 9.31. Found: C, 55.79; H, 2.91; N, 4.05; S, 9.62.

6,12-Bis(3,4-dimethylphenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15] dodeca-1,8-diene-4,11-dione 3m

Following the general method, thiazolone 2m (300 mg, 1.02 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3m as a yellow solid. Cyclobutane 3m was obtained as the mixture of two isomers in 85:15 molar ratio. Obtained: 299 mg (100% yield). Only the major ε-isomer was fully characterized. 1H NMR (CDCl3, 500.13 MHz): δ = 7.93 (m, 2H, Ho, Ph), 7.55–7.49 (m, 3H, Hp+Hm, Ph), 7.34–7.28 (m, 2H, H2 + H6, C6H3), 6.91 (d, 1H, H5, C6H3, 3JHH = 7.83 Hz), 4.61 (s, 1H, H-C6,12), 2.11 (s, 3H, C3-Me), 2.09 (s, 3H, C4-Me). 13C{1H} NMR (CDCl3, 125.76 MHz): δ = 208.0 (SC = O, C4,11), 164.2 (SC = N, C2,9), 136.4 (C1, C6H3), 135.7 (C4, C6H3), 133.7 (Ci, Ph), 132.5 (C2, C6H3), 132.0 (Cp, Ph), 130.0 (C3, C6H3), 129.0 (C5, C6H3), 128.8 (2C, Cm, Ph), 128.6 (C6, C6H3), 128.3 (2C, Co, Ph), 91.6 (Cq, C5,7), 58.3 (CH, C6,12), 19.7 (C3-Me), 19.4 (C4-Me). HRMS (ESI+) [m/z]: calcd for [C36H30N2NaO2S2]+ = [M + Na]+, 609.1646; found, 609.1651.

6,12-Bis(3,4-dichlorophenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15]dodeca-1,8-diene-4,11-dione 3n

Following the general method, thiazolone 2n (300 mg, 0.90 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3n as a yellow solid. Cyclobutane 3n was obtained as the mixture of two isomers in 91:9 molar ratio. Obtained: 298 mg (100% yield). Only the major ε-isomer was fully characterized. 1H NMR (CD2Cl2, 300.13 MHz): δ = 7.99 (m, 2H, Ho, Ph), 7.91 (d, 1H, H2, C6H3,4JHH = 2.0 Hz), 7.66–7.56 (m, 3H, Hp+Hm, Ph), 7.42 (dd, 1H, H6, C6H3, 3JHH = 8.4 Hz, 4JHH = 2.1 Hz), 7.29 (d, 1H, H5, C6H3,3JHH = 8.4 Hz), 4.62 (s, 1H, H-C6,12). 13C{1H} NMR (CD2Cl2, 75.5 MHz): δ = 206.7 (SC = O, C4,11), 166.6 (SC = N, C2,9), 133.6 (C2, C6H3), 132.8 (Cp, Ph), 132.4 (C4, C6H3), 132.2 (2C, Ci (Ph)+C1(C6H3)), 131.6 (C3, C6H3), 130.6 (C6, C6H3), 129.7 (C5, C6H3), 129.1 (2C, Cm, Ph), 128.3 (2C, Co, Ph), 89.9 (Cq, C5,7), 56.7 (CH, C6,12). HRMS (ESI+) [m/z]: calcd for [C32H18Cl4N2NaO2S2]+ = [M + Na]+, 688.9461; found, 688.9466.

6,12-Bis(3,4-difluorophenyl)-2,9-diphenyl-3,10-dithia-1,8-diazadispiro-[4.1.47.15] dodeca-1,8-diene-4,11-dione 3o

Following the general method, thiazolone 2o (300 mg, 1.00 mmol) was reacted in CH2Cl2 with blue light for 72 h to give 3o as a yellow solid. Cyclobutane 3o was obtained as the mixture of two isomers in 94:6 molar ratio. Obtained: 271 mg (90% yield). Only the major ε-isomer was fully characterized. 1H NMR (CDCl3, 500.13 MHz): δ = 7.91 (m, 2H, Ho, Ph), 7.65 (td, 1H, H6, C6H3, 3JHH = 4JFH = 9.5 Hz, 4JHH = 2.2 Hz), 7.61–7.53 (m, 3H, Hp + Hm, Ph), 7.12 (dt, 1H, H2, C6H3, 3JHF = 8.7 Hz, 4JHH = 2.2 Hz), 6.94 (q, 1H, H5, C6H3, 3JHF = 4JHF = 3JHH = 9.5 Hz), 4.59 (s, 1H, H-C6,12). 13C{1H} NMR (CDCl3, 125.76 MHz): δ = 206.9 (SC = O, C4,11), 166.3 (SC = N, C2,9), 150.4 (dd, C4-F, 1JCF = 253.2 Hz, 2JCF = 14.7 Hz), 149.5 (dd, C3-F, 1JCF = 249.6 Hz, 2JCF = 15.3 Hz), 132.9 (Ci, Ph), 132.7 (Cp, Ph), 129.2 (2C, Cm, Ph), 128.9 (m, C1, C6H3), 128.3 (2C, Co, Ph), 127.1 (t, C2, C6H3, 2JCF = 3JCF = 5.3 Hz), 120.7 (t, C6, C6H3, 2JCF = 3JCF = 10.06 Hz), 116.6 (dd, C5, C6H3, 2JFC = 14.13 Hz, 3JCF = 3.64 Hz), 90.5 (Cq, C5,7), 56.8 (CH, C6,12). 19F{1H} NMR (CDCl3, 282.4 MHz) δ = −137.37 (d, 3JFF = 9.6 Hz), −137.33 (d, 3JFF = 9.6 Hz). HRMS (ESI+) [m/z]: calcd for [C32H18F4N2NaO2S2]+ = [M + Na]+, 625.0644; found, 625.0640.

General Procedure for the [2 + 2]-Photocycloaddition of 4-Arylidene-2-phenyl-5(4H)-thiazolones 2 in the Presence of BF3: Synthesis of Cyclobutanes 4a–4e

To a suspension of the thiazolones 2a–2e (around 0.38 mmol) in dry deoxygenated methanol (3 mL) under an Ar atmosphere, BF3·OEt2 was added (200 μL, 1.621 mmol). The resulting suspension was irradiated for 24 h with the blue light provided by a Kessil lamp (PR160L, 40 W). The distance between the sample and the lamp is 5 cm, and the power of the lamp is fixed at 50% to avoid the overheating of the sample. After the reaction time, the solid in suspension is filtered, washed with MeOH, dried in vacuo, and characterized as cyclobutanes 4a–4e.

Numbering of Cyclobutanes 4a–4e, Exemplified with 4a

Methyl 8-Oxo-1,3,6-triphenyl-2-phenylthioamido-7-thia-5-azaspiro[3.4]-oct-5-ene-2-carboxylate 4a

Following the general method, thiazolone 2a (299.6 mg, 1.13 mmol) and BF3·OEt2 (600 μL, 4.863 mmol) were irradiated with blue light (456 nm) for 24 h in dry and deoxygenated methanol (9 mL) to give cyclobutane 4a as a pale-yellow solid. Obtained: 185.1 mg (59% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.66 (s, 1H, NH), 7.68 (d, 2H, Ho, NCS-Ph), 7.65 (m, 2H, Ho, NCS-Ph), 7.54 (t, 1H, Hp, NCS-Ph), 7.50–7.42 (m, 3H, Hp, Hm, NCS-Ph), 7.42–7.33 (m, 6H, Hm NCS-Ph, Ho Ph), 7.24–7.15 (m, 6H, Hm, Hp, Ph), 4.94 (s, 2H, H-C1,3), 3.88 (s, 3H, OMe). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 206.3 (SC = O, C8), 199.0 (NC = S, C9), 169.7 (COO), 166.5 (SC = N, C6), 141.2 (Ci, C6-Ph), 133.0 (Ci, C9-Ph), 132.7 (Cp, CH, C6-Ph), 132.5 (Ci, C1,3-Ph), 131.4 (Cp, CH, C9-Ph), 129.5 (Co, CH, C1,3-Ph), 129.2 (Cp, CH, C1,3-Ph), 128.7 (Cm, CH, C6-Ph), 128.7 (Cm, CH, C1,3-Ph), 128.2 (Cm, CH, C9-Ph), 128.2 (Co, CH, C6-Ph), 126.5 (Co, CH, C9-Ph), 90.8 (Cq, C4), 67.8 (Cq, C2), 55.0 (CH, C1,3), 53.1 (OMe). HRMS (ESI+) [m/z]: calcd for [C33H27N2O3S2]+ = [M + H]+, 563.1463; found, 563.1457.

Methyl 8-Oxo-6-phenyl-2-phenylthioamido-1,3-di-p-tolyl-7-thia-5-azaspiro[3.4]oct-5-ene-2-carboxylate 4b

Following the general method, thiazolone 2b (99.84 mg, 0.358 mmol) and BF3·OEt2 (200 μL, 1.621 mmol) were irradiated with blue light (456 nm) for 24 h in dry and deoxygenated methanol (3 mL) to give cyclobutane 4b as a yellow solid. Compound 4b was recrystallized from CH2Cl2/n-pentane. Obtained: 41.1 mg (39% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.64 (s, 1H, NH), 7.72 (m, 2H, Ho, NCS-Ph), 7.68 (m, 2H, Ho, NCS-Ph), 7.55 (m, 1H, Hp, NCS-Ph), 7.50–7.43 (m, 3H, Hp, Hm, NCS-Ph), 7.37 (t, 2H, Hm, NCS-Ph),7.27 (d, 4H, Hm, C6H4Me, 3JHH = 7.7 Hz), 7.00 (d, 4H, Ho, C6H4Me, 3JHH = 7.7 Hz), 4.87 (s, 2H, H-C1,3), 3.86 (s, 3H, OMe), 2.24 (s, 6H, Me). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 206.5 (SC = O, C8), 198.9 (NC = S, C9), 169.8 (COO), 166.1 (SC = N, C6), 141.4 (Ci, C6/C9-Ph), 138.5 (Ci, C1,3-C6H4Me), 138.0 (Cp, C1,3-C6H4Me), 133.1 (Ci, C6/C9-Ph), 132.6 (Cp, CH, C6/C9-Ph), 131.3 (Cp, CH, C6/C9-Ph), 129.4 (Co,C1,3-C6H4), 129.4 (Cm, C1,3-C6H4), 129.2(Cm, CH, C6/C9-Ph), 128.7 (Cm, CH, C6/C9-Ph), 128.2 (Co, CH, C6/C9-Ph), 126.6 (Co, CH, C6/C9-Ph), 91.1 (Cq, C4), 67.8 (Cq, C2), 54.9 (CH, C1,3), 53.0 (OMe), 21.3 (Me). HRMS (ESI+) [m/z]: calcd for [C35H30N2O3S2Na]+ = [M + Na]+, 613.1590; found, 613.1588.

Methyl 1,3-Bis(4-fluorophenyl)-8-oxo-6-phenyl-2-phenylthioamido-7-thia-5-azaspiro[3.4]oct-5-ene-2-carboxylate 4d

Following the general method, thiazolone 2d (100.61 mg, 0.355 mmol) and BF3·OEt2 (200 μL, 1.621 mmol) in dry and deoxygenated methanol (3 mL) were irradiated with blue light (456 nm) for 24 h to give cyclobutane 4d as a yellow solid. Compound 4d was recrystallized from CH2Cl2/n-pentane. Obtained: 34.99 mg (33% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.54 (s, 1H, NH), 7.67 (m, 2H, Ho, NCS-Ph), 7.64 (m, 2H, Ho, NCS-Ph), 7.57 (m, 1H, Hp, NCS-Ph), 7.54–7.42 (m, 3H, Hp, Hm, NCS-Ph), 7.39 (t, 2H, Hm, NCS-Ph), 7.35 (m, 4H, Ho, C6H4F), 6.90 (t, 4H, Hm, C6H4F), 4.88 (s, 2H, H-C1,3), 3.88 (s, 3H, OMe). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 205.9 (SC = O, C8), 199.0 (NC = S, C9), 169.5 (COO), 167.2 (SC = N, C6), 162.7 (d, C-F, C1,3-C6H4F, 1JFC = 248.21 Hz), 140.9 (Ci, C6/C9-Ph), 133.0 (Cp, CH, C6/C9-Ph), 132.7 (2C overlapped, Ci, C6/C9-Ph + Ci, C1,3-C6H4F), 131.7 (Cp, CH, C6/C9-Ph), 131.2 (d, Co, C1,3-C6H4F, 3JFC = 8.04 Hz), 129.4 (Cm, CH, C6/C9-Ph), 128.8 (Cm, CH, C6/C9-Ph), 128.1 (Co, CH, C6/C9-Ph), 126.4 (Co, CH, C6/C9-Ph), 115.7 (d, Cm, C1,3-C6H4F, 2JFC = 21.32 Hz), 90.6 (Cq, C4), 67.7 (Cq, C2), 54.2 (CH, C1,3), 53.2 (OMe). 19F NMR (CDCl3, 282.40 MHz) δ = −113.18 (tt, 3JFH = 8.8 Hz, 4JFH = 3.7 Hz). HRMS (ESI+) [m/z]: calcd for [C33H25F2N2O3S2]+ = [M + H]+, 599.1269; found, 599.1262.

Methyl 1,3-Bis(4-chlorophenyl)-8-oxo-6-phenyl-2-phenylthioamido-7-thia-5-azaspiro[3.4]oct-5-ene-2-carboxylate 4e

Following the general method, thiazolone 2e (100.37 mg, 0.336 mmol) and BF3·OEt2 (200 μL, 1.621 mmol) in dry and deoxygenated methanol (3 mL) were irradiated with blue light (456 nm; 100% intensity in this case to maximize the conversion) for 24 h to give cyclobutane 4e as a yellow solid. Compound 4e was recrystallized from CH2Cl2/n-pentane. Obtained: 32.27 mg (31% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.53 (s, 1H, NH), 7.67 (m, 2H, Ho, NCS-Ph), 7.64 (m, 2H, Ho, NCS-Ph), 7.57 (m, 1H, Hp, NCS-Ph), 7.53–7.44 (m, 3H, Hp, Hm, NCS-Ph), 7.40 (t, 2H, Hm, NCS-Ph), 7.29 (d, 4H, Hm, C6H4Cl, 2JHH = 8.5 Hz), 7.18 (d, 4H, Ho, C6H4Cl, 2JHH = 8.53 Hz), 4.86 (s, 2H, H-C1,3), 3.88 (s, 3H, OMe). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 205.8 (SC = O, C8), 198.1 (NC = S, C9), 169.4 (COO), 167.4 (SC = N, C6), 140.9 (Ci, C6/C9-Ph), 134.4 (Cp, C1,3-C6H4Cl), 133.1 (Cp, CH, C6/C9-Ph), 131.7 (Cp, CH, C6/C9-Ph), 132.6 (Ci, C6/C9-Ph), 132.4 (Ci, C1,3-C6H4Cl), 130.7 (Co, C1,3-C6H4Cl), 129.4 (Cm, CH, C6/C9-Ph) 128.9 (Cm, C1,3-C6H4Cl), 128.9 (Cm, CH, C6/C9-Ph), 128.1 (Co, CH, C6/C9-Ph), 126.4 (Co, CH, C6/C9-Ph), 90.4 (Cq, C4), 67.6 (Cq, C2), 54.3 (CH, C1,3), 52.2 (OMe). HRMS (ESI+) [m/z]: calcd for [C33H24Cl2N2O3S2Na]+ = [M + Na]+, 653.0498; found, 653.0506.

Reaction of Cyclobutanes 3c and 3d with NaOMe in MeOH

To a suspension of the cyclobutanes 3c or 3d (150 mg) in methanol (10 mL) was added NaOMe (10 mg). The resulting mixture was heated in an oil bath at 60 °C for 30 min. After the reaction time, the resulting solution was evaporated to dryness, and the residue was extracted with CH2Cl2 (2 × 15 mL). Any insoluble solid in the CH2Cl2 was removed by filtration. The organic phase was washed with H2O (10 mL), dried with anhydrous MgSO4, and evaporated to dryness, giving dihydrothiazoles 5c or 5d as yellow oils. Obtained: 168 mg (5c, 92% yield); 166 mg (5d, 94% yield). Compounds 5c and 5d were characterized by NMR methods as the mixture of the two possible diastereoisomers trans (RR/SS) and cis (RS/SR) in trans/cis = 86:14 (5c) and 81:19 (5d) molar ratios.

trans-(RR/SS) Methyl 5-(4-Methoxyphenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 5c

1H NMR (CDCl3, 300.13 MHz): δ = 7.92 (d, 2H, Ho, Ph, 3JHH = 7 Hz), 7.52–7.46 (m, 3H, Hp+Hm, Ph), 7.35 (AA′BB′ spin system, 2H, Ho, C6H4), 6.89 (AA′BB′ spin system, 2H, Hm, C6H4), 5.45, 5.35 (AB spin system, 2H, H4+H5, 3JHH = 6.6 Hz), 3.83 (s, 3H, CO2Me), 3.81 (s, 3H, OMe).). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.8 (CO2Me), 170.4 (SC = N), 159.5 (Cp-OMe, C6H4), 132.7, 132.2 (2C, Ci (C6H4 + Ph)), 131.8 (Cp, Ph), 128.7 (Co, C6H4), 128.6 (Co, Ph), 128.6 (Cm, Ph), 114.3 (Cm, C6H4), 86.6 (C4), 56.3 (C5), 55.3 (OMe), 52.8 (CO2Me). HRMS (ESI+) [m/z]: calcd for [C18H18NO3S]+ = [M + H]+, 328.1002; found, 328.1010.

trans-(RR/SS) Methyl 5-(4-Fluorophenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 5d

1H NMR (CDCl3, 300.13 MHz): δ = 7.92 (dd, 2H, Ho, Ph, 3JHH = 6.8 Hz, 4JHH = 1.2 Hz), 7.50–7.44 (m, 3H, Hp+Hm, Ph), 7.41 (m, 2H, Ho, C6H4), 7.02 (dd, 2H, Hm, C6H4,3JHH = 8.7 Hz, 4JFH = 2.4 Hz), 5.46, 5.33 (AB spin system, 2H, H4+H5, 3JHH = 6.5 Hz), 3.81 (s, 3H, CO2Me). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.6 (CO2Me), 170.2 (SC = N), 162.4 (d, Cp-F, C6H4, 1JCF = 248.21 Hz), 136.1 (Ci, C6H4), 132.5 (Ci, Ph), 131.9 (Cp, Ph), 129.2 (d, Co, C6H4, 3JCF=8.3 Hz), 128.7 (Co, Ph), 128.6 (Cm, Ph), 115.9 (d, Cm, C6H4, 2JCF = 21.9 Hz), 86.7 (C4), 55.9 (C5), 52.9 (CO2Me). 19F NMR (CDCl3, 282 MHz) δ = −113.15 (tt, CF, 3JFH = 8.09 Hz, 4JFH = 4.86 Hz). HRMS (ESI+) [m/z]: calcd for [C17H13FNO2S]+ = [M – H]+, 314.0657; found, 314.0649.

General Procedure for the Synthesis of trans-(RR/SS) Ethyl 5-Aryl-2-phenyl-4,5-dihydrothiazole-4-carboxylates 6

All syntheses of trans-(RR/SS) ethyl 5-aryl-2-phenyl-4,5-dihydrothiazole-4-carboxylates 6 were performed using the same experimental method, which is detailed here for the synthesis of 6c. To a suspension of thiazolone 2c (600 mg, 2.03 mmol) in 10 mL of ethanol was added NaOEt (10 mg, 0.09 mmol). The resulting mixture was refluxed (80 °C) in an oil bath for 2 h, then left to reach room temperature. The resulting solution was evaporated to dryness. The orange oily residue was extracted with CH2Cl2 (25 mL), removing all insoluble material by filtration. The clear solution was evaporated to dryness, and the residue was characterized by NMR as the dihydrotiazol 6c (mixture of the two diastereoisomers), although impure. Therefore, trans-(RR/SS)-6c (the main component of the mixture) was purified by column chromatography using silica gel as support and a mixture of n-hexane/Et2O (8:1) as an eluent. The band collected under these conditions is trans-(RR/SS)-6c. Obtained: 411 mg (58% yield).

trans-(RR/SS) Ethyl 5-(4-Methoxyphenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 6c

1H NMR (CDCl3, 300.13 MHz): δ = 7.92 (d, 2H, Ho, Ph, 3JHH = 6.9 Hz), 7.52–7.36 (m, 3H, Hp + Hm, Ph), 7.34 (d, 2H, H2, H6, C6H4OMe, 3JHH = 8.7 Hz), 6.89 (d, 2H, H3, H5, C6H4OMe, 3J = 8.7 Hz), 5.43 (AB spin system, 1H, SCH, 3JHH = 6.7 Hz), 5.32 (AB spin system, 1H, NCH, 3JHH = 6.7 Hz), 4.29 (q, 2H, OCHCH3, 3JHH = 7.1 Hz), 3.82 (s, 3H, OMe), 1.32 (t, 3H, OCH2CH, 3JHH = 7.1 Hz). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.3 (CO), 170.3 (NCS), 159.5 (C4, C6H4OMe), 132.8 (Ci, Ph), 132.3 (C1,C6H4OMe), 131.7 (CH, Cp, Ph), 128.7 (CH, Co, Ph), 128.7 (2CH, C2+C6, C6H4OMe), 128.6 (2CH, Cm, Ph), 114.3 (2CH, C3+C5, C6H4OMe), 86.8 (CH, NC4H), 61.8 (CH2), 56.5 (CH, SC5H), 55.3 (OMe), 14.2 (CH3). HRMS (ESI+) [m/z]: calcd for [C19H19NNaO3S]+ = [M + Na]+, 364.0983; found, 364.0983.

trans-(RR/SS) Ethyl 5-(4-Trifluoromethylphenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 6h

Following the general procedure, thiazolone 2h (192 mg, 0.58 mmol) was reacted with NaOEt (10 mg, 0.09 mmol) for 2 h in refluxing EtOH (10 mL) to give, after chromatographic purification using silica gel as support and n-hexane/Et2O (8:1) as an eluent, trans-(RR/SS)-6h as a waxy orange solid. Obtained: 166.5 mg (76% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.93 (d, 2H, Ho, Ph, 3JHH = 7.0 Hz), 7.65–7.46 (m, 7H, Hp+Hm, Ph; H2,6+H3,5, C6H4CF3), 5.49 (AB spin system, 1H, SCH, 3JHH = 6.3 Hz), 5.36 (AB spin system, 1H, NCH, 3JHH = 6.3 Hz), 4.31 (q, 2H, OCHCH3, 3JHH = 7.1 Hz), 3.87 (s, 3H, OMe), 1.33 (t, 3H, OCH2CH, 3JHH = 7.1 Hz). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.3 (NCS), 169.8 (CO), 144.4 (C1, C6H4CF3), 132.3 (Ci, Ph), 132.1 (Cp, Ph), 130.4 (q, C4-CF3, 2JCF = 40 Hz), 128.8 (Co, Ph), 128.7 (Cm, Ph), 128.0 (C2+C6, C6H4CF3), 126.0 (C3+C5, C6H4CF3, 3JCF = 3.8 Hz), 123.5 (CF3, 1JCF = 272 Hz), 86.4 (CH, NC4H), 62.1 (CH2), 55.9 (CH, SC5H), 14.1 (CH3). 19F NMR (CDCl3, 282.4 MHz): δ = −62.70 (s, CF3). HRMS (ESI+) [m/z]: calcd for [C19H15F3NO2S]+ = [M – H]+, 378.0781; found, 378.0797.

trans-(RR/SS) Ethyl 5-(2-Methoxyphenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 6i

Following the general procedure, thiazolone 2i (150 mg, 0.51 mmol) was reacted with NaOEt (10 mg, 0.09 mmol) for 2 h in refluxing EtOH (10 mL) to give, after chromatographic purification using silica gel as support and n-hexane/Et2O (11:1) as an eluent, trans-(RR/SS)-6i as a yellow oil. Obtained: 140 mg (80% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.93 (dd, 2H, Ho, Ph, 3JHH = 8.2 Hz, 4JHH = 1.4 Hz), 7.51 (tt, 1H, Hp, Ph, 3JHH = 8.2 Hz, 4JHH = 1.4 Hz), 7.44 (t, 2H, Hm, Ph, 3JHH = 8.2 Hz), 7.39 (dd, 1H, H6, C6H4OMe, 3JHH = 7.7 Hz, 4JHH = 0.7 Hz), 7.29 (td, 1H, H5, C6H4OMe, 3JHH = 7.7 Hz, 4JHH = 0.7 Hz), 6.96 (td, 1H, H4, C6H4OMe, 3JHH = 7.7 Hz, 4JHH = 0.7 Hz), 6.92 (d, 1H, H3, C6H4OMe, 4JHH = 0.7 Hz), 5.81 (AB spin system, 1H, NCH, 3JHH = 5.1 Hz), 5.45 (AB spin system, 1H, SCH, 3JHH = 5.1 Hz), 4.29 (q, 2H, OCHCH3, 3JHH = 7.1 Hz), 3.87 (s, 3H, OMe), 1.33 (t, 3H, OCH2CH, 3JHH = 7.1 Hz). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.9 (NCS), 170.4 (COO), 156.5 (C2-OMe, C6H4OMe), 132.9 (Ci, Ph), 131.6 (Cp, Ph), 129.2 (C4/C5, C6H4OMe), 128.8 (C1, C6H4OMe), 128.7 (Co, Ph), 128.5 (Cm, Ph), 127.8 (C6, C6H4OMe), 121.0 (C4/C5, C6H4OMe), 110.7 (C3, C6H4OMe), 84.4 (CH, NCH), 61.7 (OCH2), 55.5 (CH3, OMe), 50.4 (CH, SCH), 14.2 (CH3). HRMS (ESI+) [m/z]: calcd for [C19H19NNaO3S]+ = [M + Na]+, 364.0983; found, 364.0978.

trans-(RR/SS) Ethyl 5-(3,4-Dimethylphenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 6m

Following the general procedure, thiazolone 2m (150 mg, 0.51 mmol) was reacted with NaOEt (10 mg, 0.09 mmol) for 4 h in refluxing EtOH (10 mL) to give, after chromatographic purification using silica gel as support and n-hexane/Et2O (8:1) as an eluent, trans-(RR/SS)-6m as a yellow oil. Obtained: 129 mg (75% yield). 1H NMR (CDCl3, 300.13 MHz): 7.94 (d, 2H, Ho, Ph, 3JHH = 6.8 Hz), 7.53–7.43 (m, 3H, Hp + 2Hm, Ph), 7.19 (s, 1H, H2, C6H(Me)2), 7.16, 7.12 (AB spin system, 2H, H5 + H6, 3JHH = 7.5 Hz, C6H(Me)2), 5.41 (AB spin system, CH, 3JHH = 6.6 Hz), 5.36 (AB spin system, CH, 3JHH = 6.6 Hz), 4.31 (q, 1H, OCHCH3, 3JHH = 7.1 Hz), 4.29 (q, 1H, OCHCH3, 3JHH = 7.1 Hz), 2.27 (s, 6H, 2CH3), 1.33 (t, 3H, OCH2CH, 3JHH = 7.1 Hz). 13C{1H} NMR (CDCl3, 75.5 MHz): 170.4 (NCS), 170.4 (COO), 137.8, 137.3, 136.7 (3Cq, C1, C3, C4, CH3(Me)2), 132.7 (Ci, Ph), 131.8 (Cp, Ph), 130.2 (CH, C6/C5, C6H3(Me)2), 128.7 (Co, Ph), 128.7 (CH, C2, C6H3(Me)2), 128.6 (Cm, Ph), 124.9 (CH, C6/C5, C6H3(Me)2), 86.6 (NCH), 61.9 (OCH2), 56.5 (SCH), 19.8 (CH3), 19.5 (CH3), 14.2 (OCH2CH). HRMS (ESI+) [m/z]: calcd for [C20H22NO2S]+ = [M + H]+, 340.1366; found, 340.1359.

trans-(RR/SS) Ethyl 5-(3,4-Dichlorophenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate (6n) and Ethyl 5-(3,4-Dichlorophenyl)-2-phenylthiazole-4-carboxylate (7n)

Following the general procedure, thiazolone 2n (270 mg, 0.81 mmol) was reacted with NaOEt (10 mg, 0.09 mmol) for 2 h in refluxing EtOH (10 mL) to give a waxy orange solid. This solid is composed of dihydrothiazole 6n and thiazole 7n. These compounds were separated and purified by column chromatography using silica gel as support. Using a mixture of n-hexane/Et2O (4:1) as an eluent, the thiazole 7n eluted first. Evaporation of the solvent gave pure 7n as white crystals. Obtained: 128 mg (42% yield). Further elution with the same mixture of solvents gave trans-(RR/SS)-6n as a yellow oil. Obtained: 70 mg (24% yield)

Ethyl 5-(3,4-Dichlorophenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate (6n)

1H NMR (CDCl3, 300.13 MHz): δ = 7.93 (d, 2H, Ho, Ph, 3JHH = 7.0 Hz), 7.55–7.43 (m, 5H, Hp+Hm (Ph) + H5 + H6(C6H3Cl2)), 7.28 (s, 1H, H2, C6H3Cl2), 5.39 (AB spin system, 1H, SCH, 3JHH = 6.3 Hz), 5.31 (AB spin system, 1H, NCH, 3JHH = 6.3 Hz), 4.31 (q, 1H, OCHCH3, 3JHH = 7.1 Hz), 4.29 (q, 1H, OCHCH3, 3JHH = 7.1 Hz), 1.34 (t, 3H, OCH2CH, 3JHH = 7.1 Hz). 13C{1H} NMR (CDCl3, 75.5 MHz): 173.6 (NCS), 169.9 (CO), 140.5 (C1, C6H3Cl2), 132.2 (CH, C5/C6, C6H3Cl2), 131.0 (CH, C5/C6, C6H3Cl2), 129.6 (Cp, Ph), 128.8 (Co, Ph), 128.7 (Cm, Ph), 126.6 (CH, C2, C6H3Cl2), 86.1 (NCH), 62.2 (OCH2), 55.4 (SCH), 14.1 (CH3). Signals due to C3 and C4 (C6H3Cl2) and to the Cipso (Ph) were not observed. HRMS (ESI+) [m/z]: calcd for [C18H16Cl2NO2S]+ = [M + H]+, 380.0279; found, 380.0289.

Ethyl 5-(3,4-Dichlorophenyl)-2-phenylthiazole-4-carboxylate (7n)

1H NMR (CDCl3, 300.13 MHz): δ = 8.01 (m, 2H, Ho, Ph), 7.67 (d, 1H, H2, C6H3Cl2, 4JHH = 2 Hz), 7.54–7.48 (m, 4H, Hp+Hm (Ph) + H5(C6H3Cl2)), 7.40 (dd, 1H, H6, C6H3Cl2, 3JHH = 8.3 Hz, 4JHH = 2.1 Hz), 4.35 (q, 2H, OCHCH3, 3JHH = 7.1 Hz), 1.31 (t, 3H, OCH2CH, 3JHH = 7.1 Hz). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 166.8 (NCS), 161.9 (CO), 142.6, 142.2 (S-C=C-N), 133.5 (C, C6H3Cl2), 132.5, 132.5 (2C, C-Cl, C6H3Cl2), 131.8 (CH, C2, C6H3Cl2), 130.9 (Cp, Ph), 130.5 (Ci, Ph), 130.1 (CH, C5, C6H3Cl2), 129.3 (CH, C6, C6H3Cl2), 129.0 (Cm, Ph), 126.9 (Co, Ph), 61.5 (CH2), 14.1 (CH3). HRMS (ESI+) [m/z]: calcd for [C18H13Cl2NNaO2S]+ = [M + Na]+, 399.9942; found, 399.9945.

Microwave Synthesis of Methyl 5-(4-Nitrophenyl)-2-phenyl-4,5-thiazole-4-carboxylate 7g

To a suspension of thiazolone 2g (300 mg, 0.97 mmol) in methanol (5 mL) was added NaOMe (9 mg). The mixture was heated in a microwave oven (150 W, 70 °C) for 1 min. After the reaction time, the solvent was evaporated to dryness, and the solid residue was extracted with CH2Cl2 (10 mL). The resulting suspension was filtered through a Celite pad, and the Celite was washed with additional CH2Cl2 (20 mL). The clear solution was evaporated to dryness, and the crude was characterized by NMR and was shown to contain thiazole 7g. Compound 7g was purified by column chromatography (silica gel; n-hexane/Et2O = 5:1 as an eluent), giving pure 7g as white crystals. Obtained: 64 mg (20% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 8.33 (AB spin system, 2H, H3+H5, C6H4NO2), 8.02 (m, 2H, Ho, Ph), 7.74 (AB spin system, 2H, H2+H6, C6H4NO2), 7.51 (m, 3H, Hp+Hm, Ph), 3.91 (s, 3H, OMe). 13C{1H} NMR (CDCl3, 75.5 MHz): 167.6 (NCS), 162.3 (CO), 148.1 (C, S-C = ), 143.1 (C4-N, C6H4NO2), 141.9 (C, N-C = ), 137.0 (C1, C6H4NO2), 132.3 (Ci, Ph), 131.2 (Cp, Ph), 131.0 (C2/C6, C6H4NO2), 129.2 (Cm, Ph), 126.7 (Co, Ph), 123.4 (C3/C5, C6H4NO2), 52.6 (OCH3). HRMS (ESI+) [m/z]: calcd for [C17H12N2NaO4S]+ = [M + Na]+, 363.0415; found, 363.0410.

Synthesis of Dihydrothiazole Derivatives (cis/trans)-5 through Ring-Opening Reaction without a Base in the Presence of BF3 (General Procedure)

All syntheses of (cis/trans)-methyl 5-aryl-2-phenyl-4,5-dihydrothiazole-4-carboxylates (cis/trans)-5 were performed using the same experimental method, which is detailed here for the synthesis of 5a. To a suspension of the thiazolone 2a (100.7 mg, 0.38 mmol) in methanol (5 mL) was added BF3·OEt2 (200 μL, 1.621 mmol). The resulting mixture was heated in an oil bath at a reflux temperature with stirring for 18 h. After the reaction time, the solvent was evaporated to dryness, and the oily residue was dissolved in CH2Cl2 (5 mL). This solution was washed with H2O (3 × 2 mL), dried with anhydrous MgSO4, and evaporated to dryness, giving 5a as the mixture of the two diastereoisomers trans (RR/SS) and cis (RS/SR) in a 1:1 molar ratio. Obtained: 83.04 mg (74% yield)

(cis/trans)-Methyl 2,5-Diphenyl-4,5-dihydrothiazole-4-carboxylate 5a

1H NMR (CDCl3, 300.13 MHz): δ = 7.96 (m, Ho, NCS-Ph), 7.90 (m, Ho, NCS-Ph), 7.52–7.21 (m, Hm+Hp, NCS-Ph, Ho+Hm,+Hp, Ph, both isomers), 5.55 (d, NCH, 3JHH = 9.0 Hz, cis-isomer), 5.45 (d, SCH, 3JHH = 6.5 Hz, trans-isomer), 5.37 (d, NCH, 3JHH = 6.5 Hz, trans-isomer), 5.23 (d, SCH, 3JHH = 9.0 Hz, cis-isomer), 3.79 (s, OMe, trans-isomer), 3.34 (s, OMe, cis-isomer). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.7 (SC = N), 170.7 (COO), 170.5 (SC = N), 169.2 (COO), 140.3, 138.1 (Ci, Ph, both isomers), 132.5 (Ci, NCS-Ph, overlapped), 132.0, 131.9 (2Cp, NCS-Ph, both isomers), 129.0, 128.8, 128.7, 128.6, 128.6, 128.4, 127.9, 127.5 (Co, Cm, NCS-Ph; Co, Cm, Ph; both isomers), 128.4, 128.2 (Cp, Ph both isomers), 86.5 (NCH, trans-isomer), 83.9 (NCH, cis-isomer), 56.6 (SCH, trans-isomer), 55.8 (SCH, cis-isomer), 52.9 (OMe, trans-isomer), 51.9 (OMe, cis-isomer). HRMS (ESI+) [m/z]: calcd for [C17H16NO2S]+ = [M + H]+, 298.0896; found, 298.0893.

(cis/trans)-Methyl 2-Phenyl-5-(p-tolyl)-4,5-dihydrothiazole-4-carboxylate 5b

Following the general procedure, thiazolone 2b (101.4 mg, 0.363 mmol) was reacted with BF3·OEt2 (200 μL, 1.621 mmol) for 18 h in refluxing MeOH (5 mL) to give (cis/trans)-5b (1:1.1 molar ratio) as a yellow oil. Obtained: 80 mg (71% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.98 (m, Ho, NCS-Ph), 7.91 (m, Ho, NCS-Ph), 7.55–7.41 (m, Hm, Hp, NCS-Ph, both isomers), 7.30 (d, Ho, C6H4Me, 3JHH = 8.1 Hz), 7.16 (d, Ho, Hm, C6H4Me, 3JHH = 7.8 Hz), 7.06 (d, Hm, C6H4Me, 3JHH = 8.1 Hz), 5.55 (d, NCH, 3JHH = 8.9 Hz, cis-isomer), 5.44 (d, SCH, 3JHH = 6.6 Hz, trans-isomer), 5.36 (d, NCH, 3JHH = 6.6 Hz, trans-isomer), 5.23 (d, SCH, 3JHH = 8.9 Hz, cis-isomer), 3.82 (s, OMe, trans-isomer), 3.40 (s, OMe, cis-isomer), 2.34 (s, Me), 2.30 (s, Me). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.9 (SC = N), 170.8 (SC = N), 170.6 (COO), 169.5 (COO), 138.3 (Cp, C6H4Me), 138.2 (Cp, C6H4Me), 137.4 (Ci, C6H4Me), 135.2 (Ci, C6H4Me), 132.7 (Ci, NCS-Ph, both isomers, overlapped), 132.0, 131.9 (2Cp, NCS-Ph, both isomers), 129.8, 129.2, 128.9, 128.8, 128.7 (2C overlapped), 127.8, 127.5 (Co, Cm, NCS-Ph + Co, Cm, C6H4Me), 86.6 (NCH, trans-isomer), 84.0 (NCH, cis-isomer), 56.6 (SCH, trans-isomer), 55.8 (SCH, cis-isomer), 53.0 (OMe, trans-isomer), 52.0 (OMe, cis-isomer), 21.3 (Me), 21.2 (Me). HRMS (ESI+) [m/z]: calcd for [C18H17NO2SNa]+ = [M + Na]+, 334.0872; found, 334.0877.

(cis/trans)-Methyl 2-Phenyl-5-(4-methoxyphenyl)-4,5-dihydrothiazole-4-carboxylate 5c

Following the general procedure, thiazolone 2c (100.3 mg, 0.34 mmol) was reacted with BF3·OEt2 (200 μL, 1.621 mmol) for 18 h in refluxing MeOH (5 mL) to give (cis/trans)-5c (1:1.1 molar ratio) as a yellow oil. In this case, further chromatographic purification was necessary to separate 5c from starting thiazolone 2c. The chromatographic purification was started using silica as support and n-hexane/Et2O (9:1) as an eluent. Using these conditions, only the thiazolone 2c was eluted. Then the solvent was changed, and 2-propanol was employed. Using these conditions, the dihydrothiazole 5c was obtained as a yellow oil after solvent evaporation. Obtained: 42.7 mg (38% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.96 (m, Ho, NCS-Ph), 7.90 (m, Ho, NCS-Ph), 7.54–7.41 (m, Hm, Hp, NCS-Ph, both isomers), 7.32 (d, Ho, C6H4OMe, 3JHH = 8.1 Hz), 7.19 (d, Ho, C6H4OMe, 3JHH = 8.1 Hz), 6.87–6.78 (d, Hm, C6H4OMe, 3JHH = 8.0 Hz), 5.53 (d, NCH, 3JHH = 8.9 Hz, cis-isomer), 5.43 (d, SCH, 3JHH = 6.5 Hz, trans-isomer), 5.34 (d, NCH, 3JHH = 6.6 Hz, trans-isomer), 5.23 (d, SCH, 3JHH = 8.9 Hz, cis-isomer), 3.81 (s, OMe, trans-isomer), 3.79, 3.76 (2s, OMe, both isomers), 3.41 (s, OMe, cis-isomer). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 171.0 (SC = N), 170.9 (SC = N), 170.8 (COO), 169.4 (COO), 159.5 (Cp, C6H4OMe), 159.5 (Cp, C6H4OMe), 132.6 (Ci, NCS-Ph, both isomers), 132.2 (Ci, C6H4OMe), 132.0 (Cp, NCS-Ph), 131.9 (Cp, NCS-Ph), 130.0 (Ci, C6H4OMe), 129.1 (Co, C6H4OMe), 128.8 (Co, C6H4OMe), 128.7, 128.6 (Co, Cm, NCS-Ph, both isomers), 114.4 (Cm, C6H4OMe), 113.7 (Cm, C6H4OMe), 86.3 (NCH, trans-isomer), 83.8 (NCH, cis-isomer), 56.2 (SCH, trans-isomer), 55.4 (SCH, cis-isomer), 55.3 (OMe), 55.2 (OMe), 52.9 (COOMe).), 52.0 (COOMe). HRMS (ESI+) [m/z]: calcd for [C18H17NO3SNa]+ = [M + Na]+, 350.0821; found, 350.0823.

(cis/trans)-Methyl 5-(4-Fluorophenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 5d

Following the general procedure, thiazolone 2d (102.0 mg, 0.360 mmol) was reacted with BF3·OEt2 (200 μL, 1.621 mmol) for 18 h in refluxing MeOH (5 mL) to give (cis/trans)-5d (1:1.1 molar ratio) as a yellow oil. In this case, further chromatographic purification was necessary to separate 5d from starting thiazolone 2d. The chromatographic purification was started using silica as support and n-hexane/Et2O (9:1) as an eluent. Using these conditions, only the thiazolone 2d was eluted. Then the solvent was changed, and 2-propanol was employed. Using these conditions, the dihydrothiazole 5d was obtained as a yellow oil after solvent evaporation. Obtained: 81 mg (71% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.99 (m, Ho, NCS-Ph), 7.93 (m, Ho, NCS-Ph), 7.55–7.43 (m, Hp+Hm, NCS-Ph, both isomers), 7.40 (m, Ho, C6H4F), 7.28 (m, Ho, C6H4F), 7.06 (tt, Hm, C6H4F, 3JHF = 8.6 Hz, 4JHH = 2.1 Hz), 6.97 (tt, Hm, C6H4F, 3JHF = 8.7 Hz, 4JHH = 2.0 Hz), 5.57 (d, NCH, 3JHH = 8.9 Hz, cis-isomer), 5.47 (d, SCH, 3JHH = 6.5 Hz, trans-isomer), 5.35 (d, NCH, 3JHH = 6.5 Hz, trans-isomer), 5.26 (d, SCH, 3JHH = 8.9 Hz, cis-isomer), 3.85 (s, OMe, trans-isomer). 3.43 (s, OMe, cis-isomer). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.7 (COO), 170.5 (SC = N), 170.4 (SC = N), 169.3 (COO), 162.6 (d, Cp-F, C6H4F, 1JCF = 247.4 Hz), 162.6 (d, Cp-F, C6H4F, 1JCF = 247.7 Hz), 136.2 (d, Ci, C6H4F, 4JCF = 3.3 Hz), 134.1 (d, Ci, C6H4F, 4JCF = 3.5 Hz), 132.6 (2Ci, NCS-Ph, both isomers ovelapped), 132.1, 132.0 (2Cp, NCS-Ph, both isomers), 129.8(d, Co, C6H4F, 3JCF = 8.3 Hz), 129.3(d, Co, C6H4F, 3JCF = 8.3 Hz), 128.9, 128.8, 128.7, 128.7 (Co, Cm, NCS-Ph, both isomers), 116.0 (d, Cm, C6H4F, 2JCF = 21.7 Hz), 115.4 (d, Cm, C6H4F, 2JCF = 21.7 Hz), 86.8 (NCH, trans-isomer), 84.1 (NCH, cis-isomer), 56.0 (SCH, trans-isomer), 55.2 (SCH, cis-isomer), 53.0 (OMe). 52.0 (OMe). 19F NMR(CDCl3, 282.40 MHz): δ = −113.67 (tt, 3JFH = 8.6 Hz, 4JFH = 3.3 Hz), −113.23 (tt, 3JFH = 8.5 Hz, 4JFH = 3.3 Hz). HRMS (ESI+) [m/z]: calcd for [C17H15FNO2S]+ = [M + H]+, 316.0802; found, 316.0796.

(cis/trans)-Methyl 5-(4-Chlorophenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 5e

Following the general procedure, thiazolone 2e (300.6 mg, 1.00 mmol) was reacted with BF3·OEt2 (600 μL, 4.863 mmol) for 18 h in refluxing MeOH (15 mL) to give (cis/trans)-5e (1:1.7 molar ratio) as a yellow oil. In this case, chromatographic purification was carried out to separate (cis/trans)-5e from thiazolone 2e and to further separate cis-5e from trans-5e. The chromatographic purification was started using silica as support and n-hexane/Et2O (9:1) as an eluent. Using these conditions, only the thiazolone 2e was eluted. Then the solvent was changed, and a mixture, n-hexane/ethyl acetate (8:2), was used as an eluent. Compound trans-5e eluted first and was obtained as a yellow oil after solvent evaporation (obtained: 90 mg, 27% yield). Compound cis-5e eluted in a second fraction and was obtained as a yellow oil after solvent evaporation (obtained: 54 mg, 16% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.95 (m, Ho, NCS-Ph), 7.89 (m, Ho, NCS-Ph), 7.55–7.40 (m, Hm, Hp, NCS-Ph both isomers), 7.33 (d, Ho, Hm, C6H4Cl), 7.22 (d, Ho, Hm, C6H4Cl), 5.56 (d, NCH, 3JHH = 8.9 Hz, cis-isomer), 5.42 (d, SCH, 3JHH = 6.4 Hz, trans-isomer), 5.32 (d, NCH, 3JHH = 6.4 Hz, trans-isomer), 5.21 (d, SCH, 3JHH = 8.9 Hz, cis-isomer), 3.82 (s, OMe, trans-isomer), 3.42 (s, OMe, cis-isomer). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.7 (SC = N), 170.7 (SC = N), 170.6 (COO), 169.3 (COO), 138.2 (Ci, C6H4Cl), 136.9 (Ci, C6H4Cl), 134.4 (Cp, C6H4Cl), 134.2 (Cp, C6H4Cl), 132.5 (Ci, NCS-Ph, both isomers), 132.2(Cp, NCS-Ph), 132.1 (Cp, NCS-Ph), 129.4, 128.9 (Co, Cm C6H4Cl), 129.3, 129.0 (Co, Cm C6H4Cl), 128.8, 128.8 (Co, Cm, NCS-Ph), 128.8, 128.8 (Co, Cm, NCS-Ph), 86.6 (NCH, trans-isomer), 83.9 (NCH, cis-isomer), 56.0 (SCH, trans-isomer), 55.2 (SCH, cis-isomer), 53.1 (OMe, trans-isomer), 52.2 (OMe, cis-isomer). HRMS (ESI+) [m/z]: calcd for [C17H14ClNO2SNa]+ = [M + Na]+, 354.0326; found, 354.0325.

(cis/trans)-Methyl 5-(4-Trifluoromethylphenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 5h

Following the general procedure, thiazolone 2h (103.60 mg, 0.311 mmol) was reacted with BF3·OEt2 (200 μL, 1.621 mmol) for 18 h in refluxing MeOH (5 mL) to give (cis/trans)-5h (1:2.1 molar ratio) as a yellow oil. In this case, further chromatographic purification was necessary to separate 5h from starting thiazolone 2h. The chromatographic purification was started using silica as support and n-hexane/Et2O (9:1) as an eluant. Using these conditions, only the thiazolone 2h was eluted. Then the solvent was changed, and 2-propanol was employed. Using these conditions, the dihydrothiazole 5h was obtained as a yellow oil after solvent evaporation. Obtained: 38 mg (34% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.95 (m, Ho, NCS-Ph), 7.91 (m, Ho, NCS-Ph), 7.61 (d, Hm, C6H4-CF3,3JHH = 8.1 Hz, both isomers), 7.54–7.50 (m, Hp, NCS-Ph both isomers, Ho, C6H4-CF3), 7.40–7.42 (m, Hm, NCS-Ph, both isomers), 7.39 (d, 2H, Ho, C6H4-CF3,3JHH = 8.2 Hz), 5.60 (d, NCH, 3JHH = 8.9 Hz, cis-isomer), 5.49 (d, SCH, 3JHH = 6.4 Hz, trans-isomer), 5.35 (d, NCH, 3JHH = 6.4 Hz, trans-isomer), 5.28 (d, SCH, 3JHH = 8.9 Hz, cis-isomer), 3.83 (s, OMe, trans-isomer), 3.39 (s, OMe, cis-isomer). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 173.4 (SC = N), 172.4 (SC = N), 170.1 (COO), 168.5 (COO), 144.0 (Ci, C6H4-CF3), 141.5 (Ci, C6H4-CF3), 133.2 (Cp, NCS-Ph), 132.9 (Cp, NCS-Ph), 131.5 (Ci, NCS-Ph), 131.3 (Ci, NCS-Ph), 130.9 (q, Cp-CF3, 2JCF = 32.9 Hz), 130.8 (q, Cp-CF3, 2JCF = 32.9 Hz), 129.1, 129.1 (Co, Cm, NCS-Ph), 129.0, 129.0 (Co, Cm, NCS-Ph), 128.6 (Co, C6H4-CF3), 128.1 (Co, C6H4-CF3), 126.3 (q, Cm, C6H4-CF3, 3JCF = 3.7 Hz), 125.7 (q, Cm, C6H4-CF3, 3JCF = 3.7 Hz), 122.2 (q, CF3, 1JCF = 272 Hz), 122.1 (q, CF3, 1JCF = 272 Hz), 85.1 (NCH, trans-isomer), 82.2 (NCH, cis-isomer), 55.8 (SCH, trans-isomer), 55.0 (SCH, cis-isomer), 53.4 (OMe, trans-isomer), 52.3 (OMe, cis-isomer). 19F NMR(CDCl3, 282.40 MHz): δ = −62.76 (s), −62.70 (s). HRMS (ESI+) [m/z]: calcd for [C18H14F3NO2SNa]+ = [M + Na]+, 388.0590; found, 388.0584.

(cis/trans)-Methyl 5-(2-Bromophenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 5k

Following the general procedure, thiazolone 2k (100.4 mg, 0.293 mmol) was reacted with BF3·OEt2 (200 μL, 1.621 mmol) for 18 h in refluxing MeOH (5 mL) to give (cis/trans)-5k (1:0.8 molar ratio) as a yellow oil. In this case, further chromatographic purification was necessary to separate 5k from starting thiazolone 2k. The chromatographic purification was started using silica as support and n-hexane/Et2O (9:1) as an eluent. Using these conditions, only the thiazolone 2k was eluted. Then the solvent was changed, and 2-propanol was employed. Using these conditions, the dihydrothiazole 5k was obtained as a yellow oil after solvent evaporation. Obtained: 30 mg (27% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.93 (m, Ho, NCS-Ph), 7.90 (m, Ho, NCS-Ph), 7.59 (dd, H3, C6H4Br, 3JHH = 8.0 Hz, 4JHH = 1.2 Hz), 7.55–7.52 (m, Hp, NCS-Ph, both isomers, H3, C6H4Br), 7.49–7.42 (m, Hm, NCS-Ph, H6, C6H4Br; both isomers), 7.30 (td, H5, C6H4Br, 3JHH = 7.5 Hz, 4JHH = 1.2 Hz), 7.22 (td, H5, C6H4Br, 3JHH = 7.4 Hz, 4JHH = 1.2 Hz), 7.15 (td, H4, C6H4Br, 3JHH = 8.0 Hz, 4JHH = 1.7 Hz), 7.10 (td, H4, C6H4Br, 3JHH = 7.4 Hz, 4JHH = 1.7 Hz), 5.91 (d, SCH, 3JHH = 9.1 Hz, cis-isomer), 5.89 (d, SCH, 3JHH = 4.5 Hz, trans-isomer), 5.66 (d, NCH, 3JHH = 9.1 Hz, cis-isomer), 5.47 (d, NCH, 3JHH = 4.5 Hz, trans-isomer), 3.83 (s, OMe, trans-isomer), 3.40 (s, OMe, cis-isomer). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.9 (SC = N), 170.8 (SC = N), 170.4 (COO), 169.2 (COO), 140.2 (C1, C6H4Br), 137.9 (C1, C6H4Br), 133.2 (C3, C6H4Br), 132.8 (C3, C6H4Br), 132.7 (Ci, NCS-Ph), 132.6 (Ci, NCS-Ph), 132.1 (Cp, NCS-Ph), 132.1 (Cp, NCS-Ph), 129.8 (C4,C6H4Br), 129.7 (C4,C6H4Br), 129.2, 128.9 (Co, Cm, NCS-Ph, both isomers), 128.8 (C6, C6H4Br), 128.8 (C6, C6H4Br), 128.5 (C5, C6H4Br), 128.1 (C5, C6H4Br), 123.8 (C2-Br, C6H4Br), 123.7 (C2-Br, C6H4Br), 85.1 (NCH, trans-isomer), 82.6 (NCH, cis-isomer), 55.3 (SCH, trans-isomer), 54.5 (SCH, cis-isomer), 53.1 (OMe, trans-isomer), 52.0 (OMe, cis-isomer). HRMS (ESI+) [m/z]: calcd for [C17H14BrNO2SNa]+ = [M + Na]+, 397.9821; found, 397.9808.

(cis/trans)-Methyl 5-(3,4-Dimethylphenyl)-2-phenyl-4,5-dihydrothiazole-4-carboxylate 5m

Following the general procedure, thiazolone 2m (101.73 mg, 0.347 mmol) was reacted with BF3·OEt2 (200 μL, 1.621 mmol) for 18 h in refluxing MeOH (5 mL) to give (cis/trans)-5m (1:0.8 molar ratio) as a yellow oil. Obtained: 95 mg (84% yield). 1H NMR (CDCl3, 300.13 MHz): δ = 7.98 (m, 2H, NCS-Ph), 7.92 (m, Ho, NCS-Ph), 7.55–7.41 (m, Hm, Hp, NCS-Ph, both isomers), 7.18 (s, H2, C6H3(Me)2), 7.14–7.12 (m, H5, H6, C6H3(Me)2), 7.03 (s, H2, C6H3(Me)2), 7.02 (m, H5, H6, C6H3(Me)2), 5.55 (d, NCH, 3JHH = 9.0 Hz, cis-isomer), 5.43 (d, SCH, 3JHH = 6.7 Hz, trans-isomer), 5.38 (d, NCH, 3JHH = 6.7 Hz, trans-isomer), 5.22 (d, SCH, 3JHH = 9.0 Hz, cis-isomer), 3.82 (s, OMe, trans-isomer), 3.42 (s, OMe, cis-isomer), 2.25 (s, Me, trans-isomer). 2.20 (s, Me, cis-isomer). 13C{1H} NMR (CDCl3, 75.5 MHz): δ = 170.9 (COO + SC = N, overlapped), 170.6 (SC = N), 169.4 (COO), 137.7 (Ci, C6H3(Me)2), 137.4, 136.9, 136.8, 136.7 (Cq, C3, C4, C6H3(Me)2 both isomers), 135.5 (Ci, C6H3(Me)2), 132.7 (Ci, NCS-Ph), 132.7 (Ci, NCS-Ph), 131.9 (Cp, NCS-Ph), 131.9 (Cp, NCS-Ph), 130.3, 129.7, 125.3, 124.3 (C5, C6, C6H3(Me)2, both isomers), 129.0, 128.9, 128.6 (Co, Cm, NCS-Ph, both isomers), 128.7 (C2, C6H3(Me)2), 128.7 (C2, C6H3(Me)2), 86.5 (NCH, trans-isomer), 83.8 (NCH, cis-isomer), 56.5 (SCH, trans-isomer), 55.7 (SCH, cis-isomer), 52.9 (OMe, trans-isomer), 51.9 (OMe, cis-isomer), 19.9, 19.8, 19.5, 19.5 (Me). HRMS (ESI+) [m/z]: calcd for [C19H19NO2SNa]+ = [M + Na]+, 348.1029; found, 348.1032.
  69 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  The formal [4+3] cycloaddition between donor-acceptor cyclobutanes and nitrones.

Authors:  Andrew C Stevens; Cory Palmer; Brian L Pagenkopf
Journal:  Org Lett       Date:  2011-02-22       Impact factor: 6.005

3.  Asymmetric photoredox transition-metal catalysis activated by visible light.

Authors:  Haohua Huo; Xiaodong Shen; Chuanyong Wang; Lilu Zhang; Philipp Röse; Liang-An Chen; Klaus Harms; Michael Marsch; Gerhard Hilt; Eric Meggers
Journal:  Nature       Date:  2014-11-06       Impact factor: 49.962

4.  Enantioselective catalysis of photochemical reactions.

Authors:  Richard Brimioulle; Dominik Lenhart; Mark M Maturi; Thorsten Bach
Journal:  Angew Chem Int Ed Engl       Date:  2015-02-27       Impact factor: 15.336

5.  Stereoselective Synthesis of 1,3-Diaminotruxillic Acid Derivatives: An Advantageous Combination of C-H-ortho-Palladation and On-Flow [2+2]-Photocycloaddition in Microreactors.

Authors:  Elena Serrano; Alberto Juan; Angel García-Montero; Tatiana Soler; Francisco Jiménez-Márquez; Carlos Cativiela; M Victoria Gomez; Esteban P Urriolabeitia
Journal:  Chemistry       Date:  2015-11-24       Impact factor: 5.236

6.  Phosphine-catalyzed annulation of thioamides and 2-alkynoates: a new synthesis of thiazolines.

Authors:  Bing Liu; Roman Davis; Biren Joshi; Daniel W Reynolds
Journal:  J Org Chem       Date:  2002-06-28       Impact factor: 4.354

7.  A chiral thioxanthone as an organocatalyst for enantioselective [2+2] photocycloaddition reactions induced by visible light.

Authors:  Rafael Alonso; Thorsten Bach
Journal:  Angew Chem Int Ed Engl       Date:  2014-03-19       Impact factor: 15.336

8.  Modular synthesis of thiazoline and thiazole derivatives by using a cascade protocol.

Authors:  Zakeyah A Alsharif; Mohammad A Alam
Journal:  RSC Adv       Date:  2017-06-26       Impact factor: 3.361

9.  Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5(4H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site.

Authors:  Abeer M El-Naggar; Ibrahim H Eissa; Amany Belal; Amira A El-Sayed
Journal:  RSC Adv       Date:  2020-01-15       Impact factor: 4.036

10.  Asymmetric synthesis of 2,4,5-trisubstituted Δ2-thiazolines.

Authors:  Christoffer Bengtsson; Hanna Nelander; Fredrik Almqvist
Journal:  Chemistry       Date:  2013-06-17       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.